,active_ingredient_moiety,nda_bla,approval_year,active,DrugBank ID,Drug Groups,SMILES,Name,Drug Type,route,mw,n_hba,n_hbd,logp,tpsa,rb,h_sum,follow_mw,follow_n_hba,follow_n_hbd,follow_logp,follow_tpsa,follow_rb,follow_h_sum,follow_tpsa_or_h_sum,countplot
0,troglitazone,NDA,1997,troglitazone,DB00197,approved; investigational; withdrawn,CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O,Troglitazone,SmallMoleculeDrug,oral,441.160993964,6,2,4.374260000000004,84.86,5,8,1,1,1,1,1,1,1,1,3
1,imiquimod,NDA,1997,imiquimod,DB00724,approved; investigational,CC(C)CN1C=NC2=C1C1=C(C=CC=C1)N=C2N,Imiquimod,SmallMoleculeDrug,topical,240.137496512,4,1,2.8227,56.730000000000004,2,5,1,1,1,1,1,1,1,1,3
2,anagrelide hydrochloride,NDA,1997,anagrelide,DB00261,approved,ClC1=CC=C2N=C3NC(=O)CN3CC2=C1Cl,Anagrelide,SmallMoleculeDrug,oral,254.996617204,3,1,1.9263,44.7,0,4,1,1,1,1,1,1,1,1,3
3,nelfinavir mesylate,NDA,1997,nelfinavir,DB00220,approved,[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC1=CC=CC=C1)NC(=O)C1=C(C)C(O)=CC=C1)[C@@H](C2)C(=O)NC(C)(C)C,Nelfinavir,SmallMoleculeDrug,oral,567.31307792,6,4,4.747620000000004,101.9,9,10,0,1,1,1,1,1,1,1,3
4,delavirdine mesylate,NDA,1997,delavirdine,DB00705,approved,CC(C)NC1=C(N=CC=C1)N1CCN(CC1)C(=O)C1=CC2=C(N1)C=CC(NS(C)(=O)=O)=C2,Delavirdine,SmallMoleculeDrug,oral,456.194359756,6,3,2.7171000000000003,110.43,6,9,1,1,1,1,1,1,1,1,3
5,tamsulosin hydrochloride,NDA,1997,tamsulosin,DB00706,approved; investigational,CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC(=C(OC)C=C1)S(N)(=O)=O,Tamsulosin,SmallMoleculeDrug,oral,408.171892996,6,2,2.3409,99.88,11,8,1,1,1,1,1,0,1,1,2
6,toremifene citrate,NDA,1997,toremifene,DB00539,approved; investigational,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,Toremifene,SmallMoleculeDrug,oral,405.185942196,2,0,6.215000000000006,12.47,9,2,1,1,1,0,1,1,1,1,2
7,tazarotene,NDA,1997,tazarotene,DB00799,approved; investigational,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1,Tazarotene,SmallMoleculeDrug,topical,351.129299912,4,0,4.431500000000004,39.19,2,4,1,1,1,1,1,1,1,1,3
8,cerivastatin sodium,NDA,1997,cerivastatin,DB00439,approved; withdrawn,COCC1=C(C2=CC=C(F)C=C2)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C(C(C)C)N=C1C(C)C,Cerivastatin,SmallMoleculeDrug,oral,459.242101408,5,3,4.880700000000004,99.88000000000001,11,8,1,1,1,1,1,0,1,1,2
9,pramipexole dihydrochloride,NDA,1997,pramipexole,DB00413,approved; investigational,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Pramipexole,SmallMoleculeDrug,oral,211.114318544,4,2,1.5821999999999998,50.94,3,6,1,1,1,1,1,1,1,1,3
10,bromfenac sodium,NDA,1997,bromfenac,DB00963,approved,NC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C1,Bromfenac,SmallMoleculeDrug,ophthalmic,333.000055344,3,2,2.889400000000001,80.39,4,5,1,1,1,1,1,1,1,1,3
11,letrozole,NDA,1997,letrozole,DB01006,approved; investigational,N#CC1=CC=C(C=C1)C(N1C=NC=N1)C1=CC=C(C=C1)C#N,Letrozole,SmallMoleculeDrug,oral,285.10144535200004,5,0,2.659160000000001,78.28999999999999,3,5,1,1,1,1,1,1,1,1,3
12,dolasetron mesylate,NDA,1997,dolasetron,DB00757,approved; investigational,[H][C@@]1(C[C@@]2([H])C[C@]3([H])C[C@@]([H])(C1)N2CC3=O)OC(=O)C1=CNC2=C1C=CC=C2,Dolasetron,SmallMoleculeDrug,oral,324.1473925,4,1,2.519000000000001,62.4,2,5,1,1,1,1,1,1,1,1,3
13,arbutamine hydrochloride,NDA,1997,arbutamine,DB01102,approved,O[C@@H](CNCCCCC1=CC=C(O)C=C1)C1=CC(O)=C(O)C=C1,Arbutamine,SmallMoleculeDrug,injection,317.162708216,5,5,2.449300000000001,92.95,8,10,1,1,1,1,1,1,1,1,3
14,ropinirole hydrochloride,NDA,1997,ropinirole,DB00268,approved; investigational,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,Ropinirole,SmallMoleculeDrug,oral,260.188863388,2,1,2.845700000000001,32.34,7,3,1,1,1,1,1,1,1,1,3
15,fenoldopam mesylate,NDA,1997,fenoldopam,DB00800,approved,OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12,Fenoldopam,SmallMoleculeDrug,injection,305.081871052,4,4,2.734400000000001,72.72,1,8,1,1,1,1,1,1,1,1,3
16,quetiapine fumarate,NDA,1997,quetiapine,DB01224,approved,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Quetiapine,SmallMoleculeDrug,oral,383.16674804,6,1,2.8560000000000016,48.300000000000004,5,7,1,1,1,1,1,1,1,1,3
17,tiagabine hydrochloride,NDA,1997,tiagabine,DB00906,approved; investigational,CC1=C(SC=C1)C(=CCCN1CCC[C@H](C1)C(O)=O)C1=C(C)C=CS1,Tiagabine,SmallMoleculeDrug,oral,375.13267104,4,1,5.044840000000004,40.54,6,5,1,1,1,0,1,1,1,1,2
18,irbesartan,NDA,1997,irbesartan,DB01029,approved; investigational,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,Irbesartan,SmallMoleculeDrug,oral,428.23245951600006,5,1,4.777400000000004,87.13000000000001,7,6,1,1,1,1,1,1,1,1,3
19,grepafloxacin hydrochloride,NDA,1997,grepafloxacin,DB00365,approved; investigational; withdrawn,CC1CN(CCN1)C1=C(F)C(C)=C2C(=O)C(=CN(C3CC3)C2=C1)C(O)=O,Grepafloxacin,SmallMoleculeDrug,oral,359.16451978399994,5,2,2.28022,74.57,3,7,1,1,1,1,1,1,1,1,3
20,clopidogrel bisulfate,NDA,1997,clopidogrel,DB00758,approved,[H][C@@](N1CCC2=C(C1)C=CS2)(C(=O)OC)C1=CC=CC=C1Cl,Clopidogrel,SmallMoleculeDrug,oral,321.059027432,4,0,3.6739000000000015,29.540000000000003,3,4,1,1,1,1,1,1,1,1,3
21,sibutramine hydrochloride,NDA,1997,sibutramine,DB01105,approved; illicit; investigational; withdrawn,CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1,Sibutramine,SmallMoleculeDrug,oral,279.175377512,1,0,4.738000000000005,3.24,5,1,1,1,1,1,1,1,1,1,3
22,zolmitriptan,NDA,1997,zolmitriptan,DB00315,approved; investigational,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,Zolmitriptan,SmallMoleculeDrug,nasal oral,287.163376912,3,2,1.9229,57.36,5,5,1,1,1,1,1,1,1,1,3
23,mangafodipir trisodium,NDA,1997,mangafodipir,DB06796,approved; investigational; withdrawn,[Mn++].CC1=C(O)C(CN(CCN(CC([O-])=O)CC2=CC(COP(O)(O)=O)=NC(C)=C2O)CC([O-])=O)=CC(COP(O)(O)=O)=N1,Mangafodipir,SmallMoleculeDrug,injection,693.0759729041799,12,8,0.1941399999999985,280.84,17,20,0,0,0,1,0,0,0,0,1
24,cefdinir,NDA,1997,cefdinir,DB00535,approved,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,Cefdinir,SmallMoleculeDrug,oral,395.0358105160001,9,4,-0.1718000000000006,158.20999999999998,5,13,1,1,1,1,0,1,0,0,2
25,fomepizole,NDA,1997,fomepizole,DB01213,approved; vet_approved,CC1=CNN=C1,Fomepizole,SmallMoleculeDrug,injection,82.053098192,1,1,0.7181199999999999,28.68,0,2,1,1,1,1,1,1,1,1,3
26,raloxifene hydrochloride,NDA,1997,raloxifene,DB00481,approved; investigational,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,Raloxifene,SmallMoleculeDrug,oral,473.166079344,6,2,6.075200000000005,70.0,7,8,1,1,1,0,1,1,1,1,2
27,alatrofloxacin mesylate,NDA,1997,alatrofloxacin,DB09335,approved; withdrawn,[H][C@@]12CN(C[C@]1([H])[C@H]2NC(=O)[C@H](C)NC(=O)[C@H](C)N)C1=NC2=C(C=C1F)C(=O)C(=CN2C1=CC=C(F)C=C1F)C(O)=O,Alatrofloxacin,SmallMoleculeDrug,injection,558.1838525600001,8,4,0.9039000000000011,159.65,7,12,0,1,1,1,0,1,1,1,2
28,trovafloxacin mesylate,NDA,1997,trovafloxacin,DB00685,approved; investigational; withdrawn,[H][C@@]12CN(C[C@]1([H])[C@H]2N)C1=NC2=C(C=C1F)C(=O)C(=CN2C1=C(F)C=C(F)C=C1)C(O)=O,Trovafloxacin,SmallMoleculeDrug,oral injection,416.109625,6,2,1.8945,101.45000000000002,3,8,1,1,1,1,1,1,1,1,3
29,eprosartan mesylate,NDA,1997,eprosartan,DB00876,approved,CCCCC1=NC=C(\C=C(/CC2=CC=CS2)C(O)=O)N1CC1=CC=C(C=C1)C(O)=O,Eprosartan,SmallMoleculeDrug,oral,424.145678248,5,2,4.744400000000003,92.42000000000002,10,7,1,1,1,1,1,1,1,1,3
30,repaglinide,NDA,1997,repaglinide,DB00912,approved; investigational,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1)C(O)=O,Repaglinide,SmallMoleculeDrug,oral,452.267507632,4,2,5.219900000000005,78.87,10,6,1,1,1,0,1,1,1,1,2
31,emedastine difumarate,NDA,1997,emedastine,DB01084,approved,CCOCCN1C(=NC2=CC=CC=C12)N1CCCN(C)CC1,Emedastine,SmallMoleculeDrug,oral,302.210661452,5,0,2.2147,33.53,5,5,1,1,1,1,1,1,1,1,3
32,tolcapone,NDA,1998,tolcapone,DB00323,approved; withdrawn,CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O,Tolcapone,SmallMoleculeDrug,oral,273.06372245200004,5,2,2.545420000000002,100.66999999999999,3,7,1,1,1,1,1,1,1,1,3
33,naratriptan,NDA,1998,naratriptan,DB00952,approved; investigational,CNS(=O)(=O)CCC1=CC2=C(NC=C2C2CCN(C)CC2)C=C1,Naratriptan,SmallMoleculeDrug,oral,335.16674804,3,2,2.0687999999999995,65.2,5,5,1,1,1,1,1,1,1,1,3
34,montelukast sodium,NDA,1998,montelukast,DB00471,approved,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,Montelukast,SmallMoleculeDrug,oral,585.210442692,4,2,8.948000000000002,70.42,12,6,0,1,1,0,1,0,1,1,1
35,loteprednol etabonate,NDA,1998,loteprednol etabonate,DB14596,approved,[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)OCCl)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,Loteprednol etabonate,SmallMoleculeDrug,ophthalmic,466.175831012,7,1,3.9165000000000023,99.13,4,8,1,1,1,1,1,1,1,1,3
36,tolterodine tartrate,NDA,1998,tolterodine,DB01036,approved; investigational,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C,Tolterodine,SmallMoleculeDrug,oral,325.240564612,2,1,5.341420000000006,23.47,7,3,1,1,1,0,1,1,1,1,2
37,sildenafil citrate,NDA,1998,sildenafil,DB00203,approved; investigational,CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1,Sildenafil,SmallMoleculeDrug,oral intravenous,474.20492444,8,1,1.6109,113.41999999999999,7,9,1,1,1,1,1,1,1,1,3
38,brinzolamide,NDA,1998,brinzolamide,DB01194,approved,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,Brinzolamide,SmallMoleculeDrug,ophthalmic,383.064333772,7,2,0.0869000000000007,118.79999999999998,7,9,1,1,1,1,1,1,1,1,3
39,paricalcitol,NDA,1998,paricalcitol,DB00910,approved; investigational,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C[C@H](O)C1)[C@H](C)\C=C\[C@H](C)C(C)(C)O,Paricalcitol,SmallMoleculeDrug,intravenous,416.329045268,3,3,5.560600000000007,60.69,5,6,1,1,1,0,1,1,1,1,2
40,capecitabine,NDA,1998,capecitabine,DB01101,approved; investigational,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,Capecitabine,SmallMoleculeDrug,oral,359.1492636439999,8,3,0.7602,122.91000000000001,6,11,1,1,1,1,1,1,1,1,3
41,tirofiban hydrochloride,NDA,1998,tirofiban,DB00775,approved,CCCCS(=O)(=O)N[C@@H](CC1=CC=C(OCCCCC2CCNCC2)C=C1)C(O)=O,Tirofiban,SmallMoleculeDrug,injection intravenous,440.234493252,5,3,2.9505,104.73000000000002,14,8,1,1,1,1,1,0,1,1,2
42,rifapentine,NDA,1998,rifapentine,DB01201,approved; investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(\C=N\N1CCN(CC1)C1CCCC1)=C2O,Rifapentine,SmallMoleculeDrug,oral,876.4520734879999,15,6,5.648220000000007,220.15,5,21,0,0,0,0,0,1,0,0,1
43,rizatriptan benzoate,NDA,1998,rizatriptan,DB00953,approved,CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2,Rizatriptan,SmallMoleculeDrug,oral,269.164045608,4,1,1.9118,49.74,5,5,1,1,1,1,1,1,1,1,3
44,thalidomide,NDA,1998,thalidomide,DB01041,approved; investigational; withdrawn,O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12,Thalidomide,SmallMoleculeDrug,oral,258.0640568,4,1,0.0877999999999994,83.55000000000001,1,5,1,1,1,1,1,1,1,1,3
45,citalopram hydrobromide,NDA,1998,citalopram,DB00215,approved,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,Citalopram,SmallMoleculeDrug,oral,324.163791512,3,0,3.812980000000003,36.26,5,3,1,1,1,1,1,1,1,1,3
46,leflunomide,NDA,1998,leflunomide,DB01097,approved; investigational,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,Leflunomide,SmallMoleculeDrug,oral,270.061612188,3,1,3.254120000000001,55.13,2,4,1,1,1,1,1,1,1,1,3
47,efavirenz,NDA,1998,efavirenz,DB00625,approved; investigational,FC(F)(F)[C@]1(OC(=O)NC2=C1C=C(Cl)C=C2)C#CC1CC1,Efavirenz,SmallMoleculeDrug,oral,315.027390868,2,1,4.073100000000002,38.33,0,3,1,1,1,1,1,1,1,1,3
48,valrubicin,NDA,1998,valrubicin,DB00385,approved,[H][C@@]1(C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)COC(=O)CCCC)O[C@H]1C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1,Valrubicin,SmallMoleculeDrug,intravesical,723.213874872,13,5,2.4622,215.21999999999994,10,18,0,0,1,1,0,1,0,0,2
49,sevelamer hydrochloride,NDA,1998,sevelamer,DB00658,approved,NCC=C.ClCC1CO1,Sevelamer,SmallMoleculeDrug,oral,149.060741684,2,1,0.7550999999999999,38.55,2,3,1,1,1,1,1,1,1,1,3
50,telmisartan,NDA,1998,telmisartan,DB00966,approved; investigational,CCCC1=NC2=C(C=C(C=C2C)C2=NC3=CC=CC=C3N2C)N1CC1=CC=C(C=C1)C1=CC=CC=C1C(O)=O,Telmisartan,SmallMoleculeDrug,oral,514.2368762,5,1,7.264420000000007,72.94,7,6,0,1,1,0,1,1,1,1,2
51,abacavir sulfate,NDA,1998,abacavir,DB01048,approved; investigational,NC1=NC2=C(N=CN2[C@@H]2C[C@H](CO)C=C2)C(NC2CC2)=N1,Abacavir,SmallMoleculeDrug,oral,286.154209196,7,3,1.0922999999999998,101.88,4,10,1,1,1,1,1,1,1,1,3
52,modafinil,NDA,1998,modafinil,DB00745,approved; investigational,NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,Modafinil,SmallMoleculeDrug,oral,273.08234972,2,1,2.01,60.160000000000004,5,3,1,1,1,1,1,1,1,1,3
53,celecoxib,NDA,1998,celecoxib,DB00482,approved; investigational,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,Celecoxib,SmallMoleculeDrug,oral,381.075882348,4,1,3.5139200000000006,77.98,3,5,1,1,1,1,1,1,1,1,3
54,cilostazol,NDA,1999,cilostazol,DB01166,approved; investigational,O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2,Cilostazol,SmallMoleculeDrug,oral,369.216475104,6,1,3.4647000000000023,81.93,7,7,1,1,1,1,1,1,1,1,3
55,alitretinoin,NDA,1999,alitretinoin,DB00523,approved; investigational,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,Alitretinoin,SmallMoleculeDrug,topical,300.208930136,1,1,5.602600000000005,37.3,5,2,1,1,1,0,1,1,1,1,2
56,amprenavir,NDA,1999,amprenavir,DB00701,approved; investigational,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)C1=CC=C(N)C=C1,Amprenavir,SmallMoleculeDrug,oral,505.22465684,7,3,2.4028,131.19,11,10,0,1,1,1,1,0,1,1,2
57,orlistat,NDA,1999,orlistat,DB01083,approved; investigational,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,Orlistat,SmallMoleculeDrug,oral,495.392373796,5,1,6.881900000000007,81.69999999999999,23,6,1,1,1,0,1,0,1,1,1
58,rofecoxib,NDA,1999,rofecoxib,DB00533,approved; investigational; withdrawn,CS(=O)(=O)C1=CC=C(C=C1)C1=C(C(=O)OC1)C1=CC=CC=C1,Rofecoxib,SmallMoleculeDrug,oral,314.06127992800003,4,0,2.5577000000000005,60.44,3,4,1,1,1,1,1,1,1,1,3
59,rosiglitazone maleate,NDA,1999,rosiglitazone,DB00412,approved; investigational,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,Rosiglitazone,SmallMoleculeDrug,oral,357.11471246800005,6,1,2.490900000000001,71.53,7,7,1,1,1,1,1,1,1,1,3
60,doxercalciferol,NDA,1999,doxercalciferol,DB06410,approved,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,Doxercalciferol,SmallMoleculeDrug,injection oral,412.334130648,2,2,6.6118000000000094,40.46,5,4,1,1,1,0,1,1,1,1,2
61,ketotifen fumarate,NDA,1999,ketotifen,DB00920,approved,CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=CC=CC=C12,Ketotifen,SmallMoleculeDrug,ophthalmic,309.11873522800005,3,0,4.014400000000004,20.310000000000002,0,3,1,1,1,1,1,1,1,1,3
62,pioglitazone hydrochloride,NDA,1999,pioglitazone,DB01132,approved; investigational,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,Pioglitazone,SmallMoleculeDrug,oral,356.1194635,5,1,3.159600000000001,68.28999999999999,7,6,1,1,1,1,1,1,1,1,3
63,zanamivir,NDA,1999,zanamivir,DB00558,approved; investigational,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,Zanamivir,SmallMoleculeDrug,inhalation,332.13319898,7,7,-3.7854999999999976,200.71999999999997,6,14,1,1,0,1,0,1,0,0,2
64,ganirelix acetate,NDA,1999,ganirelix,DB06785,approved,CCNC(NCC)=NCCCC[C@@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,Ganirelix,SmallMoleculeDrug,injection,1568.842303355999,16,16,2.272699999999999,451.48999999999984,44,32,0,0,0,1,0,0,0,0,1
65,temozolomide,NDA,1999,temozolomide,DB00853,approved; investigational,CN1N=NC2=C(N=CN2C1=O)C(N)=O,Temozolomide,SmallMoleculeDrug,oral intravenous,194.055223432,7,1,-2.078099999999999,108.17000000000002,1,8,1,1,1,1,1,1,1,1,3
66,zaleplon,NDA,1999,zaleplon,DB00962,approved; illicit; investigational,CCN(C(C)=O)C1=CC=CC(=C1)C1=CC=NC2=C(C=NN12)C#N,Zaleplon,SmallMoleculeDrug,oral,305.12766010000007,5,0,2.6407800000000003,74.28999999999999,3,5,1,1,1,1,1,1,1,1,3
67,rapacuronium bromide,NDA,1999,rapacuronium,DB04834,approved; withdrawn,[H][C@@]12C[C@@H]([C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(CC=C)CCCCC1,Rapacuronium,SmallMoleculeDrug,injection,597.46258485209,5,0,6.912200000000008,55.84,7,5,0,1,1,0,1,1,1,1,2
68,rabeprazole sodium,NDA,1999,rabeprazole,DB01129,approved; investigational,COCCCOC1=C(C)C(CS(=O)C2=NC3=CC=CC=C3N2)=NC=C1,Rabeprazole,SmallMoleculeDrug,oral,359.13036253200005,5,1,2.989420000000001,77.10000000000001,8,6,1,1,1,1,1,1,1,1,3
69,epirubicin hydrochloride,NDA,1999,epirubicin,DB00445,approved,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,Epirubicin,SmallMoleculeDrug,injection,543.1740607479999,12,6,0.0012999999999995,206.06999999999996,5,18,0,0,0,1,0,1,0,0,2
70,sirolimus,NDA,1999,sirolimus,DB00877,approved; investigational,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,Sirolimus,SmallMoleculeDrug,oral intravenous,913.5551415880002,13,3,6.180600000000007,195.42999999999995,6,16,0,0,1,0,0,1,0,0,1
71,dofetilide,NDA,1999,dofetilide,DB00204,approved; investigational,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,Dofetilide,SmallMoleculeDrug,oral,441.139212964,6,2,1.9829,104.81,11,8,1,1,1,1,1,0,1,1,2
72,entacapone,NDA,1999,entacapone,DB00494,approved; investigational,CCN(CC)C(=O)C(=C\C1=CC(=C(O)C(O)=C1)[N+]([O-])=O)\C#N,Entacapone,SmallMoleculeDrug,oral,305.10117058000003,6,2,1.7813800000000002,127.69999999999999,5,8,1,1,1,1,1,1,1,1,3
73,exemestane,NDA,1999,exemestane,DB00990,approved; investigational,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=C)C2=CC(=O)C=C[C@]12C,Exemestane,SmallMoleculeDrug,oral,296.177630008,2,0,4.029500000000003,34.14,0,2,1,1,1,1,1,1,1,1,3
74,oseltamivir phosphate,NDA,1999,oseltamivir,DB00198,approved,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,Oseltamivir,SmallMoleculeDrug,oral,312.204907376,5,2,1.2853999999999997,90.64999999999999,7,7,1,1,1,1,1,1,1,1,3
75,levetiracetam,NDA,1999,levetiracetam,DB01202,approved,CC[C@H](N1CCCC1=O)C(N)=O,Levetiracetam,SmallMoleculeDrug,oral intravenous,170.105527688,2,1,-0.1272999999999998,63.4,3,3,1,1,1,1,1,1,1,1,3
76,aminolevulinic acid hydrochloride,NDA,1999,aminolevulinic acid,DB00855,approved,NCC(=O)CCC(O)=O,Aminolevulinic acid,SmallMoleculeDrug,oral topical,131.058243148,3,2,-0.6210000000000004,80.39000000000001,4,5,1,1,1,1,1,1,1,1,3
77,gadoversetamide,NDA,1999,gadoversetamide,DB00538,approved; investigational,[Gd+3].COCCNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NCCOC)CC([O-])=O)CC([O-])=O,Gadoversetamide,SmallMoleculeDrug,injection,507.2540423839999,10,5,-3.3285999999999945,198.27999999999997,22,15,0,1,1,1,0,0,0,0,1
78,moxifloxacin hydrochloride,NDA,1999,moxifloxacin,DB00218,approved; investigational,[H][C@]12CN(C[C@@]1([H])NCCC2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1OC)C(O)=O,Moxifloxacin,SmallMoleculeDrug,ophthalmic intravenous,401.1750844679999,6,2,2.3705,83.80000000000001,4,8,1,1,1,1,1,1,1,1,3
79,dexmedetomidine hydrochloride,NDA,1999,dexmedetomidine,DB00633,approved; vet_approved,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1,Dexmedetomidine,SmallMoleculeDrug,injection intravenous,200.131348512,1,1,3.178340000000002,28.68,2,2,1,1,1,1,1,1,1,1,3
80,gatifloxacin,NDA,1999,gatifloxacin,DB01044,approved; investigational,COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1)C1CC1,Gatifloxacin,SmallMoleculeDrug,ophthalmic,375.159434404,6,2,1.9804,83.8,4,8,1,1,1,1,1,1,1,1,3
81,nitric oxide,NDA,1999,nitric oxide,DB00435,approved,[N]=O,Nitric Oxide,SmallMoleculeDrug,inhalation,29.99798862,1,0,-0.4471,39.370000000000005,0,1,1,1,1,1,1,1,1,1,3
82,bexarotene,NDA,1999,bexarotene,DB00307,approved; investigational,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C,Bexarotene,SmallMoleculeDrug,oral topical,348.208930136,1,1,6.103720000000005,37.3,3,2,1,1,1,0,1,1,1,1,2
83,cevimeline hydrochloride,NDA,2000,cevimeline,DB00185,approved,CC1O[C@@]2(CS1)CN1CCC2CC1,Cevimeline,SmallMoleculeDrug,oral,199.103085164,3,0,1.5602,12.47,0,3,1,1,1,1,1,1,1,1,3
84,oxcarbazepine,NDA,2000,oxcarbazepine,DB00776,approved,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,Oxcarbazepine,SmallMoleculeDrug,oral,252.089877624,2,1,2.6422000000000008,63.400000000000006,0,3,1,1,1,1,1,1,1,1,3
85,pantoprazole sodium,NDA,2000,pantoprazole,DB00213,approved,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,Pantoprazole,SmallMoleculeDrug,oral intravenous,383.0751334,6,1,2.8843000000000014,86.33000000000001,7,7,1,1,1,1,1,1,1,1,3
86,alosetron hydrochloride,NDA,2000,alosetron,DB00969,approved; withdrawn,CN1C2=C(C3=CC=CC=C13)C(=O)N(CC1=C(C)NC=N1)CC2,Alosetron,SmallMoleculeDrug,oral,294.148061196,3,1,2.4083200000000007,53.92,2,4,1,1,1,1,1,1,1,1,3
87,zonisamide,NDA,2000,zonisamide,DB00909,approved; investigational,NS(=O)(=O)CC1=NOC2=CC=CC=C12,Zonisamide,SmallMoleculeDrug,oral,212.025563116,4,1,0.6163,86.19000000000001,2,5,1,1,1,1,1,1,1,1,3
88,verteporfin,NDA,2000,verteporfin,DB00460,approved; investigational,COC(=O)CCC1=C2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(CCC(O)=O)=C5C)C(C=C)=C4C)C2=CC=C([C@@H](C(=O)OC)[C@@]32C)C(=O)OC)=C1C,Verteporfin,SmallMoleculeDrug,injection,718.3002643040002,9,3,6.719240000000006,173.55999999999997,9,12,0,1,1,0,0,1,1,1,1
89,meloxicam,NDA,2000,meloxicam,DB00814,approved; vet_approved,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=C(C=CC=C2)S1(=O)=O,Meloxicam,SmallMoleculeDrug,oral intravenous,351.034747896,6,2,1.95092,99.6,2,8,1,1,1,1,1,1,1,1,3
90,linezolid,NDA,2000,linezolid,DB00601,approved; investigational,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,Linezolid,SmallMoleculeDrug,oral intravenous,337.14378434,5,1,1.1235999999999997,71.11,4,6,1,1,1,1,1,1,1,1,3
91,rivastigmine tartrate,NDA,2000,rivastigmine,DB00989,approved; investigational,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,Rivastigmine,SmallMoleculeDrug,transdermal,250.168127944,3,0,2.7597000000000014,32.78,4,3,1,1,1,1,1,1,1,1,3
92,argatroban,NDA,2000,argatroban,DB00278,approved; investigational,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2,Argatroban,SmallMoleculeDrug,injection intravenous,508.246789252,6,6,0.9125700000000044,177.70999999999998,9,12,0,1,0,1,0,1,1,1,2
93,balsalazide disodium,NDA,2000,balsalazide,DB01014,approved; investigational,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,Balsalazide,SmallMoleculeDrug,oral,357.09608519999995,6,4,2.7103,148.65,7,10,1,1,1,1,0,1,1,1,2
94,docosanol,NDA,2000,docosanol,DB00632,approved; investigational,CCCCCCCCCCCCCCCCCCCCCCO,Docosanol,SmallMoleculeDrug,topical,326.35486609199995,1,1,7.800600000000008,20.23,20,2,1,1,1,0,1,0,1,1,1
95,cetrorelix acetate,NDA,2000,cetrorelix,DB00050,approved; investigational,CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,Cetrorelix,SmallMoleculeDrug,injection,1429.6698183039996,16,17,-0.5061300000000057,495.6699999999998,38,33,0,0,0,1,0,0,0,0,1
96,arsenic trioxide,NDA,2000,arsenic trioxide,DB01169,approved; investigational,O=[As]O[As]=O,Arsenic trioxide,SmallMoleculeDrug,injection,197.82793686,3,0,-1.0676,43.370000000000005,2,3,1,1,1,1,1,1,1,1,3
97,mifepristone,NDA,2000,mifepristone,DB00834,approved; investigational,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H],Mifepristone,SmallMoleculeDrug,oral,429.26677936,3,1,5.406500000000006,40.54,2,4,1,1,1,0,1,1,1,1,2
98,bivalirudin,NDA,2000,bivalirudin,DB00006,approved; investigational,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,Bivalirudin,SmallMoleculeDrug,intravenous,2178.9858128759984,29,28,-8.116429999999925,901.5700000000002,66,57,0,0,0,1,0,0,0,0,1
99,nateglinide,NDA,2000,nateglinide,DB00731,approved; investigational,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,Nateglinide,SmallMoleculeDrug,oral,317.199093724,2,2,3.260900000000001,66.4,6,4,1,1,1,1,1,1,1,1,3
100,caspofungin acetate,NDA,2001,caspofungin,DB00520,approved,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,Caspofungin,SmallMoleculeDrug,intravenous,1092.6430621160002,18,16,-3.311900000000018,412.03,23,34,0,0,0,1,0,0,0,0,1
101,ziprasidone hydrochloride,NDA,2001,ziprasidone,DB00246,approved,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Ziprasidone,SmallMoleculeDrug,intramuscular oral,412.112459972,5,1,3.809000000000002,48.47,4,6,1,1,1,1,1,1,1,1,3
102,formoterol fumarate,NDA,2001,formoterol,DB00983,approved; investigational,COC1=CC=C(CC(C)NCC(O)C2=CC(NC=O)=C(O)C=C2)C=C1,Formoterol,SmallMoleculeDrug,inhalation,344.173607248,5,4,2.2233,90.82000000000001,9,9,1,1,1,1,1,1,1,1,3
103,galantamine hydrobromide,NDA,2001,galantamine,DB00674,approved,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,Galantamine,SmallMoleculeDrug,oral,287.152143532,4,1,1.8503,41.93000000000001,1,5,1,1,1,1,1,1,1,1,3
104,travoprost,NDA,2001,travoprost,DB00287,approved,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,Travoprost,SmallMoleculeDrug,ophthalmic,500.2385735,6,3,4.427400000000004,96.22000000000001,12,9,0,1,1,1,1,0,1,1,2
105,bimatoprost,NDA,2001,bimatoprost,DB00905,approved; investigational,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,Bimatoprost,SmallMoleculeDrug,ophthalmic topical,415.272258664,4,4,3.1469000000000014,89.79,12,8,1,1,1,1,1,0,1,1,2
106,almotriptan malate,NDA,2001,almotriptan,DB00918,approved; investigational,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2,Almotriptan,SmallMoleculeDrug,oral,335.16674804,3,1,2.1976,56.410000000000004,6,4,1,1,1,1,1,1,1,1,3
107,imatinib mesylate,NDA,2001,imatinib,DB00619,approved,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,Imatinib,SmallMoleculeDrug,oral,493.25900861200006,7,2,4.590320000000004,86.28,7,9,1,1,1,1,1,1,1,1,3
108,zoledronic acid,NDA,2001,zoledronic acid,DB00399,approved,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,Zoledronic acid,SmallMoleculeDrug,intravenous,271.99632391999995,5,5,-1.1154000000000002,153.11,4,10,1,1,1,1,0,1,1,1,2
109,tenofovir disoproxil fumarate,NDA,2001,tenofovir disoproxil,DB00300,approved; investigational,[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,Tenofovir disoproxil,SmallMoleculeDrug,oral,519.1730287899999,15,1,3.0356000000000014,185.43999999999997,13,16,0,0,1,1,0,0,0,0,1
110,frovatriptan,NDA,2001,frovatriptan,DB00998,approved; investigational,CN[C@@H]1CCC2=C(C1)C1=C(N2)C=CC(=C1)C(N)=O,Frovatriptan,SmallMoleculeDrug,oral,243.137162164,2,3,1.3435,70.91,2,5,1,1,1,1,1,1,1,1,3
111,valdecoxib,NDA,2001,valdecoxib,DB00580,approved; investigational; withdrawn,CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O,Valdecoxib,SmallMoleculeDrug,oral,314.07251330799994,4,1,2.9644200000000005,86.19,3,5,1,1,1,1,1,1,1,1,3
112,dutasteride,NDA,2001,dutasteride,DB01126,approved; investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])NC(=O)C=C[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)NC1=CC(=CC=C1C(F)(F)F)C(F)(F)F,Dutasteride,SmallMoleculeDrug,oral,528.22114752,2,2,6.576100000000006,58.2,2,4,0,1,1,0,1,1,1,1,2
113,bosentan,NDA,2001,bosentan,DB00559,approved; investigational,COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)N=C(N=C1OCCO)C1=NC=CC=N1,Bosentan,SmallMoleculeDrug,oral,551.1838546480001,10,2,4.203900000000004,145.64999999999998,10,12,0,1,1,1,0,1,1,1,2
114,ertapenem sodium,NDA,2001,ertapenem,DB00303,approved; investigational,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,Ertapenem,SmallMoleculeDrug,intramuscular intravenous,475.1413211399999,7,5,0.9406999999999996,156.27,7,12,1,1,1,1,0,1,1,1,2
115,fondaparinux sodium,NDA,2001,fondaparinux,DB00569,approved; investigational,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O,Fondaparinux,SmallMoleculeDrug,subcutaneous,1506.9513330759987,39,19,-13.750099999999987,805.4800000000005,30,58,0,0,0,1,0,0,0,0,1
116,pimecrolimus,NDA,2001,pimecrolimus,DB00337,approved; investigational,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,Pimecrolimus,SmallMoleculeDrug,topical,809.448089676,11,2,5.719400000000006,158.13,6,13,0,0,1,0,0,1,0,0,1
117,desloratadine,NDA,2001,desloratadine,DB00967,approved; investigational,ClC1=CC2=C(C=C1)C(=C1CCNCC1)C1=C(CC2)C=CC=N1,Desloratadine,SmallMoleculeDrug,oral,310.12367628800007,2,1,4.018900000000002,24.92,0,3,1,1,1,1,1,1,1,1,3
118,nitisinone,NDA,2002,nitisinone,DB00348,approved; investigational,[O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O,Nitisinone,SmallMoleculeDrug,oral,329.05110707999995,5,0,2.7346000000000004,94.35,3,5,1,1,1,1,1,1,1,1,3
119,fulvestrant,NDA,2002,fulvestrant,DB00947,approved; investigational,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],Fulvestrant,SmallMoleculeDrug,intramuscular,606.3166074639998,3,2,8.682600000000004,57.53,14,5,0,1,1,0,1,0,1,1,1
120,treprostinil sodium,NDA,2002,treprostinil,DB00374,approved; investigational,[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=C(C2)C(OCC(O)=O)=CC=C1,Treprostinil,SmallMoleculeDrug,injection subcutaneous inhalation,390.2406241879999,4,3,3.5832000000000024,86.99000000000001,10,7,1,1,1,1,1,1,1,1,3
121,voriconazole,NDA,2002,voriconazole,DB00582,approved,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,Voriconazole,SmallMoleculeDrug,oral intravenous,349.115044728,6,1,2.1769,76.72,5,7,1,1,1,1,1,1,1,1,3
122,tegaserod maleate,NDA,2002,tegaserod,DB01079,approved; investigational; withdrawn,CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2,Tegaserod,SmallMoleculeDrug,oral,301.190260356,3,4,2.8145700000000007,85.29,7,7,1,1,1,1,1,1,1,1,3
123,adefovir dipivoxil,NDA,2002,adefovir dipivoxil,DB00718,approved; investigational,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C12)OCOC(=O)C(C)(C)C,Adefovir dipivoxil,SmallMoleculeDrug,oral,501.198849614,13,1,2.702500000000001,166.97999999999996,11,14,0,0,1,1,0,0,0,0,1
124,eplerenone,NDA,2002,eplerenone,DB00700,approved,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)C[C@H]1O[C@@]11[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)C(=O)OC,Eplerenone,SmallMoleculeDrug,oral,414.2042386799999,6,0,3.124500000000002,82.2,1,6,1,1,1,1,1,1,1,1,3
125,ezetimibe,NDA,2002,ezetimibe,DB00973,approved,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,Ezetimibe,SmallMoleculeDrug,oral,409.148949972,3,2,4.888300000000004,60.769999999999996,6,5,1,1,1,1,1,1,1,1,3
126,aripiprazole,NDA,2002,aripiprazole,DB01238,approved; investigational,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Aripiprazole,SmallMoleculeDrug,oral intramuscular,447.148032464,4,1,4.859300000000004,44.81,7,5,1,1,1,1,1,1,1,1,3
127,nitazoxanide,NDA,2002,nitazoxanide,DB00507,approved; investigational; vet_approved,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,Nitazoxanide,SmallMoleculeDrug,oral,307.026291388,7,1,2.2289000000000003,111.43,4,8,1,1,1,1,1,1,1,1,3
128,atomoxetine hydrochloride,NDA,2002,atomoxetine,DB00289,approved,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,Atomoxetine,SmallMoleculeDrug,oral,255.162314292,2,1,3.7246200000000034,21.259999999999998,6,3,1,1,1,1,1,1,1,1,3
129,eletriptan hydrobromide,NDA,2002,eletriptan,DB00216,approved; investigational,CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,Eletriptan,SmallMoleculeDrug,oral,382.171499072,3,1,3.8210000000000015,53.17,6,4,1,1,1,1,1,1,1,1,3
130,aprepitant,NDA,2003,aprepitant,DB00673,approved; investigational,C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,Aprepitant,SmallMoleculeDrug,oral intravenous,534.150188072,5,2,4.952100000000003,83.24000000000001,6,7,0,1,1,1,1,1,1,1,3
131,gemifloxacin mesylate,NDA,2003,gemifloxacin,DB01155,approved; investigational,CO\N=C1/CN(CC1CN)C1=NC2=C(C=C1F)C(=O)C(=CN2C1CC1)C(O)=O,Gemifloxacin,SmallMoleculeDrug,oral,389.14993234,8,2,0.9660000000000002,123.04000000000002,5,10,1,1,1,1,1,1,1,1,3
132,gefitinib,NDA,2003,gefitinib,DB00317,approved; investigational,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,Gefitinib,SmallMoleculeDrug,oral,446.1520965280001,7,1,4.2756000000000025,68.74000000000001,8,8,1,1,1,1,1,1,1,1,3
133,bortezomib,NDA,2003,bortezomib,DB00188,approved; investigational,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,Bortezomib,SmallMoleculeDrug,intravenous subcutaneous,384.19688568,6,4,0.3605999999999996,124.44000000000001,9,10,1,1,1,1,1,1,1,1,3
134,alfuzosin hydrochloride,NDA,2003,alfuzosin,DB00346,approved; investigational,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N(C)CCCNC(=O)C1CCCO1,Alfuzosin,SmallMoleculeDrug,oral,389.206304344,8,2,1.3507,111.83,8,10,1,1,1,1,1,1,1,1,3
135,atazanavir sulfate,NDA,2003,atazanavir,DB01072,approved; investigational,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,Atazanavir,SmallMoleculeDrug,oral,704.3897480040001,9,5,4.2116000000000025,171.21999999999997,14,14,0,1,1,1,0,0,0,0,1
136,emtricitabine,NDA,2003,emtricitabine,DB00879,approved; investigational,NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1,Emtricitabine,SmallMoleculeDrug,oral,247.0426904,7,2,-0.4550000000000002,90.37,2,9,1,1,1,1,1,1,1,1,3
137,palonosetron hydrochloride,NDA,2003,palonosetron,DB00377,approved; investigational,[H][C@]12CCCC3=C1C(=CC=C3)C(=O)N(C2)[C@@H]1CN2CCC1CC2,Palonosetron,SmallMoleculeDrug,injection oral,296.188863388,2,0,2.656500000000001,23.550000000000004,1,2,1,1,1,1,1,1,1,1,3
138,miglustat,NDA,2003,miglustat,DB00419,approved,CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,Miglustat,SmallMoleculeDrug,oral,219.147058152,5,4,-1.4542999999999997,84.16000000000001,4,9,1,1,1,1,1,1,1,1,3
139,rosuvastatin calcium,NDA,2003,rosuvastatin,DB01098,approved,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,Rosuvastatin,SmallMoleculeDrug,oral,481.1682848359999,7,3,2.401700000000001,140.92,10,10,1,1,1,1,0,1,1,1,2
140,vardenafil hydrochloride,NDA,2003,vardenafil,DB00862,approved,CCCC1=NC(C)=C2N1NC(=NC2=O)C1=C(OCC)C=CC(=C1)S(=O)(=O)N1CCN(CC)CC1,Vardenafil,SmallMoleculeDrug,oral,488.220574504,8,1,2.0704199999999995,112.89999999999998,8,9,1,1,1,1,1,1,1,1,3
141,daptomycin,NDA,2003,daptomycin,DB00080,approved; investigational,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,Daptomycin,SmallMoleculeDrug,intravenous,1619.710366351999,24,22,-5.621799999999977,702.02,35,46,0,0,0,1,0,0,0,0,1
142,prussian blue,NDA,2003,prussian blue,DB06783,approved,[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N.N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N.N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N,Prussian blue,SmallMoleculeDrug,oral,859.5998944999999,18,0,0.28454,428.2200000000001,0,18,0,0,1,1,0,1,0,0,2
143,epinastine hydrochloride,NDA,2003,epinastine,DB00751,approved; investigational,NC1=NCC2N1C1=CC=CC=C1CC1=CC=CC=C21,Epinastine,SmallMoleculeDrug,ophthalmic,249.12659748,3,1,2.4668,41.62,0,4,1,1,1,1,1,1,1,1,3
144,memantine hydrochloride,NDA,2003,memantine,DB01043,approved; investigational,CC12CC3CC(C)(C1)CC(N)(C3)C2,Memantine,SmallMoleculeDrug,oral,179.167399672,1,1,2.6941000000000006,26.02,0,2,1,1,1,1,1,1,1,1,3
145,tadalafil,NDA,2003,tadalafil,DB00820,approved; investigational,[H][C@]12CC3=C(NC4=CC=CC=C34)[C@H](N1C(=O)CN(C)C2=O)C1=CC2=C(OCO2)C=C1,Tadalafil,SmallMoleculeDrug,oral,389.137556088,4,1,2.2113000000000005,74.87,1,5,1,1,1,1,1,1,1,1,3
146,abarelix,NDA,2003,abarelix,DB00106,approved; investigational; withdrawn,CC(C)C[C@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=C(C=CC=C2)C=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,Abarelix,SmallMoleculeDrug,intramuscular,1414.6840713999995,16,13,1.1680000000000077,424.9799999999998,38,29,0,0,0,1,0,0,0,0,1
147,sertaconazole nitrate,NDA,2003,sertaconazole,DB01153,approved; investigational,ClC1=CC(Cl)=C(C=C1)C(CN1C=CN=C1)OCC1=CSC2=C1C=CC=C2Cl,Sertaconazole,SmallMoleculeDrug,topical,435.99706714,4,0,7.016100000000004,27.05,6,4,1,1,1,0,1,1,1,1,2
148,tiotropium bromide,NDA,2004,tiotropium,DB01409,approved,[H][C@]12O[C@@]1([H])[C@]1([H])C[C@@]([H])(C[C@@]2([H])[N+]1(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1,Tiotropium,SmallMoleculeDrug,inhalation,392.0984766040901,6,1,2.345700000000001,59.06,4,7,1,1,1,1,1,1,1,1,3
149,pemetrexed disodium,NDA,2004,pemetrexed,DB00642,approved; investigational,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,Pemetrexed,SmallMoleculeDrug,intravenous,427.149183392,6,6,0.6663999999999999,191.26,9,12,1,1,0,1,0,1,1,1,2
150,cinacalcet hydrochloride,NDA,2004,cinacalcet,DB01012,approved,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,Cinacalcet,SmallMoleculeDrug,oral,357.170434364,1,1,6.142000000000005,12.03,6,2,1,1,1,0,1,1,1,1,2
151,telithromycin,NDA,2004,telithromycin,DB00976,approved,[H][C@@]12[C@@H](C)C(=O)[C@H](C)C[C@@](C)(OC)[C@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@H](CC)[C@@]1(C)OC(=O)N2CCCCN1C=NC(=C1)C1=CC=CN=C1,Telithromycin,SmallMoleculeDrug,oral,811.4731432799998,14,1,4.929200000000005,171.85000000000002,11,15,0,0,1,1,0,0,0,0,1
152,apomorphine hydrochloride,NDA,2004,apomorphine,DB00714,approved; investigational,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23,Apomorphine,SmallMoleculeDrug,subcutaneous sublingual,267.125928784,3,2,2.8499000000000008,43.7,0,5,1,1,1,1,1,1,1,1,3
153,tinidazole,NDA,2004,tinidazole,DB00911,approved; investigational,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O,Tinidazole,SmallMoleculeDrug,oral,247.062676896,6,0,0.5344199999999997,95.1,5,6,1,1,1,1,1,1,1,1,3
154,azacitidine,NDA,2004,azacitidine,DB00928,approved; investigational,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,Azacitidine,SmallMoleculeDrug,intravenous subcutaneous oral,244.080769484,9,4,-3.167999999999999,143.72,2,13,1,1,1,1,0,1,0,0,2
155,rifaximin,NDA,2004,rifaximin,DB01220,approved; investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C1=C(N=C5C=C(C)C=CN15)C4=C3C2=O,Rifaximin,SmallMoleculeDrug,oral,785.3523594519999,13,5,6.157840000000006,198.37999999999997,2,18,0,0,1,0,0,1,0,0,1
156,trospium chloride,NDA,2004,trospium,DB00209,approved,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,Trospium,SmallMoleculeDrug,oral,392.22202024009,3,1,3.769700000000003,46.53,4,4,1,1,1,1,1,1,1,1,3
157,l-glutamine,NDA,2004,l-glutamine,DB00130,approved; investigational; nutraceutical,N[C@@H](CCC(N)=O)C(O)=O,L-Glutamine,SmallMoleculeDrug,oral,146.06914218,3,3,-1.3361999999999998,106.41,4,6,1,1,1,1,1,1,1,1,3
158,acamprosate calcium,NDA,2004,acamprosate,DB00659,approved; investigational,CC(=O)NCCCS(O)(=O)=O,Acamprosate,SmallMoleculeDrug,oral,181.040878832,3,2,-0.5995999999999997,83.47,4,5,1,1,1,1,1,1,1,1,3
159,duloxetine hydrochloride,NDA,2004,duloxetine,DB00476,approved,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Duloxetine,SmallMoleculeDrug,oral,297.11873522800005,3,1,4.630900000000003,21.259999999999998,6,4,1,1,1,1,1,1,1,1,3
160,erlotinib hydrochloride,NDA,2004,erlotinib,DB00530,approved; investigational,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Erlotinib,SmallMoleculeDrug,oral,393.1688562160001,7,1,3.405100000000002,74.73,10,8,1,1,1,1,1,1,1,1,3
161,solifenacin succinate,NDA,2004,solifenacin,DB01591,approved,O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1,Solifenacin,SmallMoleculeDrug,oral,362.199428072,3,0,3.864900000000003,32.78,2,3,1,1,1,1,1,1,1,1,3
162,eszopiclone,NDA,2004,eszopiclone,DB00402,approved; investigational,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,Eszopiclone,SmallMoleculeDrug,oral,388.105066084,7,0,1.5679999999999998,91.76,2,7,1,1,1,1,1,1,1,1,3
163,darifenacin hydrobromide,NDA,2004,darifenacin,DB00496,approved; investigational,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,Darifenacin,SmallMoleculeDrug,oral,426.2307282,3,1,3.957500000000002,55.56,7,4,1,1,1,1,1,1,1,1,3
164,ziconotide,NDA,2004,ziconotide,DB06283,approved,[H][C@]12CSSC[C@]3([H])NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CSSC[C@]([H])(NC(=O)[C@]([H])(CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC1=O)C(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC3=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N2,Ziconotide,SmallMoleculeDrug,intrathecal,2637.098334344001,45,42,-16.212859999999985,1133.84,38,87,0,0,0,1,0,0,0,0,1
165,iloprost,NDA,2004,iloprost,DB01088,approved; investigational,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O,Iloprost,SmallMoleculeDrug,inhalation,360.23005950399994,3,3,3.5413000000000023,77.75999999999999,8,6,1,1,1,1,1,1,1,1,3
166,pregabalin,NDA,2004,pregabalin,DB00230,approved; investigational,CC(C)C[C@H](CN)CC(O)=O,Pregabalin,SmallMoleculeDrug,oral,159.125928784,2,2,1.0821,63.32,5,4,1,1,1,1,1,1,1,1,3
167,pramlintide acetate,NDA,2005,pramlintide,DB01278,approved; investigational,[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@]([H])(NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O,Pramlintide,SmallMoleculeDrug,subcutaneous,3946.920674404006,59,56,-23.82513000000038,1690.6399999999987,109,115,0,0,0,1,0,0,0,0,1
168,micafungin sodium,NDA,2005,micafungin,DB01141,approved; investigational,CCCCCOC1=CC=C(C=C1)C1=CC(=NO1)C1=CC=C(C=C1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C1=CC(OS(O)(=O)=O)=C(O)C=C1)[C@H](O)CC(N)=O,Micafungin,SmallMoleculeDrug,intravenous,1269.4383505319995,23,16,-3.9019999999999984,510.14000000000004,18,39,0,0,0,1,0,0,0,0,1
169,entecavir,NDA,2005,entecavir,DB00442,approved; investigational,NC1=NC(=O)C2=C(N1)N(C=N2)[C@H]1C[C@H](O)[C@@H](CO)C1=C,Entecavir,SmallMoleculeDrug,oral,277.11748934,7,4,-0.8278000000000003,130.04999999999998,2,11,1,1,1,1,1,1,1,1,3
170,tigecycline,NDA,2005,tigecycline,DB00560,approved,[H][C@@]12CC3=C(C(O)=C(NC(=O)CNC(C)(C)C)C=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,Tigecycline,SmallMoleculeDrug,intravenous,585.2798632079998,11,7,0.5132000000000037,205.76,6,18,0,0,0,1,0,1,0,0,2
171,tipranavir,NDA,2005,tipranavir,DB00932,approved; investigational,[H][C@@](CC)(C1=CC(NS(=O)(=O)C2=NC=C(C=C2)C(F)(F)F)=CC=C1)C1=C(O)C[C@@](CCC)(CCC2=CC=CC=C2)OC1=O,Tipranavir,SmallMoleculeDrug,oral,602.2062278160001,6,2,7.325500000000007,105.59,11,8,0,1,1,0,1,0,1,1,1
172,ramelteon,NDA,2005,ramelteon,DB00980,approved; investigational,CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2,Ramelteon,SmallMoleculeDrug,oral,259.157228912,2,1,2.5676000000000005,38.33,4,3,1,1,1,1,1,1,1,1,3
173,nepafenac,NDA,2005,nepafenac,DB06802,approved; investigational,NC(=O)CC1=CC=CC(C(=O)C2=CC=CC=C2)=C1N,Nepafenac,SmallMoleculeDrug,ophthalmic,254.105527688,3,2,1.5276,86.18,4,5,1,1,1,1,1,1,1,1,3
174,nelarabine,NDA,2005,nelarabine,DB01280,approved; investigational,COC1=NC(N)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,Nelarabine,SmallMoleculeDrug,intravenous,297.10731858,10,4,-1.9713999999999996,148.76999999999998,3,14,1,1,1,1,0,1,0,0,2
175,deferasirox,NDA,2005,deferasirox,DB01609,approved; investigational,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,Deferasirox,SmallMoleculeDrug,oral,373.10625596,6,3,3.7107000000000014,108.47,4,9,1,1,1,1,1,1,1,1,3
176,sorafenib tosylate,NDA,2005,sorafenib,DB00398,approved; investigational,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Sorafenib,SmallMoleculeDrug,oral,464.086302712,4,3,5.549700000000002,92.35,5,7,1,1,1,0,1,1,1,1,2
177,lenalidomide,NDA,2005,lenalidomide,DB00480,approved,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,Lenalidomide,SmallMoleculeDrug,oral,259.095691276,4,2,0.0297999999999998,92.5,1,6,1,1,1,1,1,1,1,1,3
178,conivaptan hydrochloride,NDA,2005,conivaptan,DB00872,approved; investigational,CC1=NC2=C(CCN(C(=O)C3=CC=C(NC(=O)C4=CC=CC=C4C4=CC=CC=C4)C=C3)C3=CC=CC=C23)N1,Conivaptan,SmallMoleculeDrug,intravenous,498.205576072,3,2,6.507320000000005,78.09,4,5,1,1,1,0,1,1,1,1,2
179,sunitinib malate,NDA,2006,sunitinib,DB01268,approved; investigational,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Sunitinib,SmallMoleculeDrug,oral,398.211804324,3,3,3.3349400000000013,77.23,7,6,1,1,1,1,1,1,1,1,3
180,ranolazine,NDA,2006,ranolazine,DB00243,approved; investigational,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1,Ranolazine,SmallMoleculeDrug,oral,427.2471065360001,6,2,2.30804,74.27,9,8,1,1,1,1,1,1,1,1,3
181,lubiprostone,NDA,2006,lubiprostone,DB01046,approved; investigational,[H][C@@]12CC(=O)[C@H](CCCCCCC(O)=O)[C@@]1([H])CC[C@@](O)(O2)C(F)(F)CCCC,Lubiprostone,SmallMoleculeDrug,oral,390.221780564,4,2,4.309900000000003,83.83,11,6,1,1,1,1,1,0,1,1,2
182,anidulafungin,NDA,2006,anidulafungin,DB00362,approved; investigational,[H][C@]1(NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)[C@H](C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C1=O)NC(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CC=C(OCCCCC)C=C1)[C@@H](C)O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@@H](C)O,Anidulafungin,SmallMoleculeDrug,intravenous,1139.506293876,17,14,-0.9270999999999918,377.4200000000001,14,31,0,0,0,1,0,0,0,0,1
183,decitabine,NDA,2006,decitabine,DB01262,approved; investigational,NC1=NC(=O)N(C=N1)[C@H]1C[C@H](O)[C@@H](CO)O1,Decitabine,SmallMoleculeDrug,intravenous,228.085854864,8,3,-2.1388,123.49000000000001,2,11,1,1,1,1,1,1,1,1,3
184,varenicline,NDA,2006,varenicline,DB01273,approved; investigational,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,Varenicline,SmallMoleculeDrug,nasal,211.110947416,3,1,1.8039,37.81,0,4,1,1,1,1,1,1,1,1,3
185,rasagiline mesylate,NDA,2006,rasagiline,DB01367,approved,C#CCN[C@@H]1CCC2=CC=CC=C12,Rasagiline,SmallMoleculeDrug,oral,171.104799416,1,1,1.8967,12.03,2,2,1,1,1,1,1,1,1,1,3
186,darunavir,NDA,2006,darunavir,DB01264,approved,[H][C@@]12CCO[C@]1([H])OC[C@@H]2OC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](O)CN(CC(C)C)S(=O)(=O)C1=CC=C(N)C=C1,Darunavir,SmallMoleculeDrug,oral,547.2352215239999,8,3,2.3753,140.42000000000002,11,11,0,1,1,1,0,0,1,1,1
187,dasatinib,NDA,2006,dasatinib,DB01254,approved; investigational,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Dasatinib,SmallMoleculeDrug,oral,487.155721752,9,3,3.313540000000001,106.50999999999999,7,12,1,1,1,1,1,1,1,1,3
188,posaconazole,NDA,2006,posaconazole,DB01263,approved; investigational; vet_approved,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,Posaconazole,SmallMoleculeDrug,oral intravenous,700.329708264,12,1,4.573200000000004,115.70000000000002,12,13,0,0,1,1,1,0,0,1,2
189,vorinostat,NDA,2006,vorinostat,DB02546,approved; investigational,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,Vorinostat,SmallMoleculeDrug,oral,264.1473925,3,3,2.4711,78.43,8,6,1,1,1,1,1,1,1,1,3
190,sitagliptin phosphate,NDA,2006,sitagliptin,DB01261,approved; investigational,N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=CC(F)=C(F)C=C1F,Sitagliptin,SmallMoleculeDrug,oral,407.11807942,5,1,2.0165,77.04,4,6,1,1,1,1,1,1,1,1,3
191,ciclesonide,NDA,2006,ciclesonide,DB01410,approved; investigational,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,Ciclesonide,SmallMoleculeDrug,inhalation nasal,540.3087037479999,7,1,4.703900000000004,99.13000000000002,5,8,0,1,1,1,1,1,1,1,3
192,telbivudine,NDA,2006,telbivudine,DB01265,approved; investigational,CC1=CN([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O,Telbivudine,SmallMoleculeDrug,oral,242.090271548,6,3,-1.5142799999999992,104.54999999999998,2,9,1,1,1,1,1,1,1,1,3
193,paliperidone,NDA,2006,paliperidone,DB01267,approved,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Paliperidone,SmallMoleculeDrug,oral,426.206718944,7,1,3.081320000000002,84.39,4,8,1,1,1,1,1,1,1,1,3
194,lisdexamfetamine dimesylate,NDA,2007,lisdexamfetamine,DB01255,approved; investigational,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,Lisdexamfetamine,SmallMoleculeDrug,oral,263.19976242,3,3,1.1901,81.14,8,6,1,1,1,1,1,1,1,1,3
195,aliskiren,NDA,2007,aliskiren,DB09026,approved; investigational,COCCCOC1=C(OC)C=CC(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)=C1,Aliskiren,SmallMoleculeDrug,oral,551.393436416,7,4,3.2935000000000025,146.13,19,11,0,1,1,1,0,0,1,1,1
196,lapatinib,NDA,2007,lapatinib,DB01259,approved; investigational,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Lapatinib,SmallMoleculeDrug,oral,580.134732212,8,2,6.139100000000005,106.35000000000001,11,10,0,1,1,0,1,0,1,1,1
197,retapamulin,NDA,2007,retapamulin,DB01256,approved,[H][C@@]12C(=O)CC[C@]11CC[C@@H](C)[C@@]2(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]1C)OC(=O)CS[C@H]1C[C@@H]2CC[C@H](C1)N2C,Retapamulin,SmallMoleculeDrug,topical,517.322579984,6,1,5.251300000000006,66.84,5,7,0,1,1,0,1,1,1,1,2
198,rotigotine,NDA,2007,rotigotine,DB05271,approved,CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1,Rotigotine,SmallMoleculeDrug,transdermal,315.16568542000005,3,1,4.265700000000003,23.47,6,4,1,1,1,1,1,1,1,1,3
199,temsirolimus,NDA,2007,temsirolimus,DB06287,approved,OCC(C)(CO)C(=O)O[C@@H]1CC[C@@H](C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@@H](OC)C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)C[C@H]1OC,Temsirolimus,SmallMoleculeDrug,intravenous,1029.6024857040002,16,4,5.722400000000008,241.95999999999995,10,20,0,0,1,0,0,1,0,0,1
200,ambrisentan,NDA,2007,ambrisentan,DB06403,approved; investigational,COC([C@H](OC1=NC(C)=CC(C)=N1)C(O)=O)(C1=CC=CC=C1)C1=CC=CC=C1,Ambrisentan,SmallMoleculeDrug,oral,378.157957184,5,1,3.515640000000002,81.53999999999999,7,6,1,1,1,1,1,1,1,1,3
201,maraviroc,NDA,2007,maraviroc,DB04835,approved; investigational,CC(C)C1=NN=C(C)N1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)C1=CC=CC=C1,Maraviroc,SmallMoleculeDrug,oral,513.327917372,5,1,5.950920000000006,63.050000000000004,8,6,0,1,1,0,1,1,1,1,2
202,lanreotide,NDA,2007,lanreotide,DB06791,approved,[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H],Lanreotide,SmallMoleculeDrug,subcutaneous,1095.467029408,14,13,0.8216000000000097,355.07999999999987,17,27,0,0,0,1,0,0,0,0,1
203,doripenem,NDA,2007,doripenem,DB06211,approved; investigational,[H][C@]12[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,Doripenem,SmallMoleculeDrug,injection,420.113726488,7,5,-1.6030999999999962,162.06,7,12,1,1,1,1,0,1,1,1,2
204,raltegravir,NDA,2007,raltegravir,DB06817,approved,CN1C(=O)C(O)=C(N=C1C(C)(C)NC(=O)C1=NN=C(C)O1)C(=O)NCC1=CC=C(F)C=C1,Raltegravir,SmallMoleculeDrug,oral,444.155745992,9,3,0.91152,152.24,6,12,1,1,1,1,0,1,1,1,2
205,ixabepilone,NDA,2007,ixabepilone,DB04845,approved; investigational,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1,Ixabepilone,SmallMoleculeDrug,intravenous,506.28144344399993,7,3,4.050520000000002,112.05000000000001,2,10,0,1,1,1,1,1,1,1,3
206,nilotinib,NDA,2007,nilotinib,DB04868,approved; investigational,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,Nilotinib,SmallMoleculeDrug,oral,529.1837929840001,7,2,6.355840000000003,97.62,6,9,0,1,1,0,1,1,1,1,2
207,sapropterin dihydrochloride,NDA,2007,sapropterin,DB00360,approved; investigational,[H][C@@]1(CNC2=C(N1)C(=O)NC(N)=N2)[C@@H](O)[C@H](C)O,Sapropterin,SmallMoleculeDrug,oral,241.11748934,7,6,-1.7002,136.29,2,13,1,1,0,1,1,1,0,1,3
208,nebivolol,NDA,2007,nebivolol,DB04861,approved; investigational,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,Nebivolol,SmallMoleculeDrug,oral,405.17516472,5,3,2.3636,70.95,6,8,1,1,1,1,1,1,1,1,3
209,etravirine,NDA,2008,etravirine,DB06414,approved,CC1=CC(=CC(C)=C1OC1=C(Br)C(N)=NC(NC2=CC=C(C=C2)C#N)=N1)C#N,Etravirine,SmallMoleculeDrug,oral,434.0490712000001,7,2,4.717400000000003,120.64000000000001,4,9,1,1,1,1,1,1,1,1,3
210,desvenlafaxine,NDA,2008,desvenlafaxine,DB06700,approved; investigational,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Desvenlafaxine,SmallMoleculeDrug,oral,263.18852904,3,2,2.7326000000000006,43.7,4,5,1,1,1,1,1,1,1,1,3
211,bendamustine hydrochloride,NDA,2008,bendamustine,DB06769,approved; investigational,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,Bendamustine,SmallMoleculeDrug,injection,357.10108227200004,4,1,3.2646000000000024,58.36000000000001,9,5,1,1,1,1,1,1,1,1,3
212,regadenoson,NDA,2008,regadenoson,DB06213,approved; investigational,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,Regadenoson,SmallMoleculeDrug,intravenous,390.140015676,12,5,-2.434699999999998,186.46000000000004,4,17,1,0,1,1,0,1,0,0,2
213,methylnaltrexone bromide,NDA,2008,methylnaltrexone,DB06800,approved,C[N@+]1(CC2CC2)CC[C@]23[C@H]4OC5=C(O)C=CC(C[C@@H]1[C@]2(O)CCC4=O)=C35,Methylnaltrexone,SmallMoleculeDrug,subcutaneous oral,356.18563473209,4,2,1.6699999999999997,66.75999999999999,2,6,1,1,1,1,1,1,1,1,3
214,alvimopan,NDA,2008,alvimopan,DB06274,approved; investigational,C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C1,Alvimopan,SmallMoleculeDrug,oral,424.236207504,4,3,3.051400000000001,89.87000000000002,8,7,1,1,1,1,1,1,1,1,3
215,difluprednate,NDA,2008,difluprednate,DB06781,approved,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,Difluprednate,SmallMoleculeDrug,ophthalmic,508.227259868,7,1,3.5195000000000025,106.97000000000003,6,8,0,1,1,1,1,1,1,1,3
216,clevidipine,NDA,2008,clevidipine,DB04920,approved; investigational,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,Clevidipine,SmallMoleculeDrug,intravenous,455.090242816,7,1,4.245200000000003,90.92999999999999,7,8,1,1,1,1,1,1,1,1,3
217,tetrabenazine,NDA,2008,tetrabenazine,DB04844,approved; investigational,COC1=C(OC)C=C2C3CC(=O)C(CC(C)C)CN3CCC2=C1,Tetrabenazine,SmallMoleculeDrug,oral,317.199093724,4,0,3.238100000000002,38.77,4,4,1,1,1,1,1,1,1,1,3
218,silodosin,NDA,2008,silodosin,DB06207,approved,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,Silodosin,SmallMoleculeDrug,oral,495.2344911639999,6,3,3.0711000000000013,97.05000000000001,13,9,1,1,1,1,1,0,1,1,2
219,lacosamide,NDA,2008,lacosamide,DB06218,approved,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,Lacosamide,SmallMoleculeDrug,oral intravenous,250.131742436,3,2,0.4539000000000007,67.42999999999999,6,5,1,1,1,1,1,1,1,1,3
220,fesoterodine fumarate,NDA,2008,fesoterodine,DB06702,approved,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C,Fesoterodine,SmallMoleculeDrug,oral,411.277344044,4,1,5.381100000000006,49.769999999999996,10,5,1,1,1,0,1,1,1,1,2
221,rufinamide,NDA,2008,rufinamide,DB06201,approved,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,Rufinamide,SmallMoleculeDrug,oral,238.066617316,4,1,0.7035000000000001,73.80000000000001,3,5,1,1,1,1,1,1,1,1,3
222,eltrombopag,NDA,2008,eltrombopag,DB06210,approved,CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC=CC(=C2)C(O)=O)=C1O)C1=CC=C(C)C(C)=C1,Eltrombopag,SmallMoleculeDrug,oral,442.164105184,6,3,4.564840000000003,114.59000000000002,5,9,1,1,1,1,1,1,1,1,3
223,tapentadol,NDA,2008,tapentadol,DB06204,approved,CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1,Tapentadol,SmallMoleculeDrug,oral,221.177964356,2,1,3.0835000000000017,23.47,5,3,1,1,1,1,1,1,1,1,3
224,fospropofol disodium,NDA,2008,fospropofol,DB06716,approved; illicit; investigational,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O,Fospropofol,SmallMoleculeDrug,injection,288.112660402,3,2,3.379000000000003,75.99000000000001,6,5,1,1,1,1,1,1,1,1,3
225,plerixafor,NDA,2008,plerixafor,DB06809,approved,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,Plerixafor,SmallMoleculeDrug,subcutaneous,502.44714372800007,8,6,0.4158000000000071,78.66,4,14,0,1,0,1,1,1,0,1,3
226,degarelix,NDA,2008,degarelix,DB06699,approved,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=C(NC(N)=O)C=C1)NC(=O)[C@H](CC1=CC=C(NC(=O)[C@@H]2CC(=O)NC(=O)N2)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,Degarelix,SmallMoleculeDrug,subcutaneous,1630.7487968959992,18,17,1.5146999999999973,512.8699999999998,41,35,0,0,0,1,0,0,0,0,1
227,milnacipran hydrochloride,NDA,2009,milnacipran,DB04896,approved; investigational,CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1,Milnacipran,SmallMoleculeDrug,oral,246.173213324,2,1,1.7713999999999996,46.33,5,3,1,1,1,1,1,1,1,1,3
228,febuxostat,NDA,2009,febuxostat,DB04854,approved,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,Febuxostat,SmallMoleculeDrug,oral,316.088163372,5,1,3.723200000000002,83.21000000000001,5,6,1,1,1,1,1,1,1,1,3
229,everolimus,NDA,2009,everolimus,DB01590,approved,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](OCCO)[C@@H](C1)OC,Everolimus,SmallMoleculeDrug,oral,957.5813563360002,14,3,6.1972000000000085,204.65999999999994,9,17,0,0,1,0,0,1,0,0,1
230,benzyl alcohol,NDA,2009,benzyl alcohol,DB06770,approved,OCC1=CC=CC=C1,Benzyl alcohol,SmallMoleculeDrug,topical,108.057514876,1,1,1.1789,20.23,1,2,1,1,1,1,1,1,1,1,3
231,iloperidone,NDA,2009,iloperidone,DB04946,approved,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O,Iloperidone,SmallMoleculeDrug,oral,426.195485564,6,0,4.826600000000004,64.80000000000001,8,6,1,1,1,1,1,1,1,1,3
232,tolvaptan,NDA,2009,tolvaptan,DB06212,approved,CC1=CC=CC=C1C(=O)NC1=CC(C)=C(C=C1)C(=O)N1CCC[C@@H](O)C2=C1C=CC(Cl)=C2,Tolvaptan,SmallMoleculeDrug,oral,448.15537034,3,2,5.683140000000005,69.64,3,5,1,1,1,0,1,1,1,1,2
233,besifloxacin,NDA,2009,besifloxacin,DB06771,approved,N[C@@H]1CCCCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O,Besifloxacin,SmallMoleculeDrug,ophthalmic,393.125547432,5,2,3.144700000000001,88.56,3,7,1,1,1,1,1,1,1,1,3
234,dronedarone,NDA,2009,dronedarone,DB04855,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,Dronedarone,SmallMoleculeDrug,oral,556.2970935079999,6,1,7.049000000000008,88.85,18,7,0,1,1,0,1,0,1,1,1
235,prasugrel,NDA,2009,prasugrel,DB06209,approved,CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1,Prasugrel,SmallMoleculeDrug,oral,373.11479272,5,0,3.891000000000004,46.61,5,5,1,1,1,1,1,1,1,1,3
236,saxagliptin,NDA,2009,saxagliptin,DB06335,approved,[H][C@@]12C[C@]1([H])N([C@@H](C2)C#N)C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2,Saxagliptin,SmallMoleculeDrug,oral,315.19467704,4,2,1.157979999999999,90.35000000000001,2,6,1,1,1,1,1,1,1,1,3
237,pitavastatin,NDA,2009,pitavastatin,DB08860,approved,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,Pitavastatin,SmallMoleculeDrug,oral,421.168936468,4,3,4.518100000000004,90.65,8,7,1,1,1,1,1,1,1,1,3
238,asenapine,NDA,2009,asenapine,DB06216,approved,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,Asenapine,SmallMoleculeDrug,transdermal sublingual,285.092041812,2,0,4.258500000000003,12.47,0,2,1,1,1,1,1,1,1,1,3
239,vigabatrin,NDA,2009,vigabatrin,DB01080,approved,NC(CCC(O)=O)C=C,Vigabatrin,SmallMoleculeDrug,oral,129.078978592,2,2,0.3645,63.32,4,4,1,1,1,1,1,1,1,1,3
240,bepotastine besilate,NDA,2009,bepotastine,DB04890,approved,OC(=O)CCCN1CCC(CC1)OC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1,Bepotastine,SmallMoleculeDrug,ophthalmic,388.1553703400001,4,1,4.170200000000004,62.66,8,5,1,1,1,1,1,1,1,1,3
241,telavancin,NDA,2009,telavancin,DB06402,approved,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC2=C3OC4=CC=C(C=C4Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]4C(C=C2OC2=C(Cl)C=C(C=C2)[C@@H](O)[C@@H]2NC(=O)[C@H](NC4=O)C4=CC(=C(O)C=C4)C4=C(O)C(CNCP(O)(O)=O)=C(O)C=C4[C@H](NC2=O)C(O)=O)=C3)O[C@@H](C)[C@H]1O,Telavancin,SmallMoleculeDrug,intravenous,1753.6374291219986,28,23,2.6922000000000152,598.0900000000001,30,51,0,0,0,1,0,0,0,0,1
242,pralatrexate,NDA,2009,pralatrexate,DB06813,approved; investigational,NC1=NC2=NC=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N=C2C(N)=N1,Pralatrexate,SmallMoleculeDrug,intravenous,477.176066836,9,5,0.9815999999999996,207.3,10,14,1,1,1,1,0,1,0,0,2
243,pazopanib,NDA,2009,pazopanib,DB06589,approved,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1,Pazopanib,SmallMoleculeDrug,oral,437.163393976,8,2,3.1390400000000005,119.02999999999999,5,10,1,1,1,1,1,1,1,1,3
244,romidepsin,NDA,2009,romidepsin,DB06176,approved; investigational,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,Romidepsin,SmallMoleculeDrug,intravenous,540.207626872,8,4,1.4296000000000009,142.70000000000002,2,12,0,1,1,1,0,1,1,1,2
245,capsaicin,NDA,2009,capsaicin,DB06774,approved,COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1,Capsaicin,SmallMoleculeDrug,topical,305.199093724,3,2,3.7896000000000023,58.56,9,5,1,1,1,1,1,1,1,1,3
246,dalfampridine,NDA,2010,dalfampridine,DB06637,approved,NC1=CC=NC=C1,Dalfampridine,SmallMoleculeDrug,oral,94.053098192,2,1,0.6638000000000001,38.91,0,3,1,1,1,1,1,1,1,1,3
247,carglumic acid,NDA,2010,carglumic acid,DB06775,approved,NC(=O)N[C@@H](CCC(O)=O)C(O)=O,Carglumic acid,SmallMoleculeDrug,oral,190.05897142,3,4,-1.0273000000000003,129.72000000000003,5,7,1,1,1,1,1,1,1,1,3
248,polidocanol,NDA,2010,polidocanol,DB06811,approved,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,Polidocanol,SmallMoleculeDrug,intravenous,582.4342981839999,10,1,4.049000000000006,103.30000000000003,37,11,0,1,1,1,1,0,1,1,2
249,cabazitaxel,NDA,2010,cabazitaxel,DB06772,approved,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C4=CC=CC=C4)C(C)=C([C@@H](OC)C(=O)[C@]1(C)[C@H](C[C@H]1OC[C@@]21OC(C)=O)OC)C3(C)C,Cabazitaxel,SmallMoleculeDrug,intravenous,835.3779055040002,14,3,4.567800000000004,202.44999999999996,10,17,0,0,1,1,0,1,0,0,2
250,alcaftadine,NDA,2010,alcaftadine,DB06766,approved,CN1CCC(CC1)=C1C2=NC=C(C=O)N2CCC2=CC=CC=C12,Alcaftadine,SmallMoleculeDrug,ophthalmic,307.168462292,4,0,2.779200000000001,38.13,1,4,1,1,1,1,1,1,1,1,3
251,ulipristal acetate,NDA,2010,ulipristal,DB08867,approved,CN(C)C1=CC=C(C=C1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12,Ulipristal,SmallMoleculeDrug,oral,433.26169398,4,1,4.972200000000005,57.61,3,5,1,1,1,1,1,1,1,1,3
252,fingolimod,NDA,2010,fingolimod,DB08868,approved; investigational,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1,Fingolimod,SmallMoleculeDrug,oral,307.25112929600004,3,3,3.204300000000001,66.48,12,6,1,1,1,1,1,0,1,1,2
253,dabigatran etexilate mesylate,NDA,2010,dabigatran etexilate,DB06695,approved,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,Dabigatran etexilate,SmallMoleculeDrug,oral,627.316917412,9,2,5.602600000000005,154.02999999999997,15,11,0,1,1,0,0,0,1,1,0
254,lurasidone hydrochloride,NDA,2010,lurasidone,DB08815,approved; investigational,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,Lurasidone,SmallMoleculeDrug,oral,492.255897392,6,0,4.255800000000003,56.75000000000001,5,6,1,1,1,1,1,1,1,1,3
255,ceftaroline fosamil,NDA,2010,ceftaroline fosamil,DB06590,approved; investigational,[H][C@]12SCC(SC3=NC(=CS3)C3=CC=[N+](C)C=C3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OCC)\C1=NSC(NP(O)(O)=O)=N1)C([O-])=O,Ceftaroline fosamil,SmallMoleculeDrug,intravenous,685.0175567140901,13,5,1.2196999999999991,220.41,11,18,0,0,1,1,0,0,0,0,1
256,eribulin mesylate,NDA,2010,eribulin,DB08871,approved; investigational,[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@H]7O[C@@]8(C[C@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2,Eribulin,SmallMoleculeDrug,intravenous,729.408811708,12,2,3.438000000000005,146.39000000000001,4,14,0,0,1,1,0,1,0,0,2
257,spinosad,NDA,2011,spinosad,DB08823,approved; investigational; vet_approved,[H][C@]1(C[C@@]2([H])C=C[C@@]3([H])[C@]4([H])CC(=O)O[C@@]([H])(CC)CCC[C@]([H])(O[C@@]5([H])CC[C@]([H])(N(C)C)[C@@]([H])(C)O5)[C@@]([H])(C)C(=O)C4=C[C@@]3([H])[C@]2([H])C1)O[C@]1([H])O[C@@]([H])(C)[C@]([H])(OC)[C@@]([H])(OC)[C@@]1([H])OC.[H][C@]1(C[C@@]2([H])C(C)=C[C@@]3([H])[C@]4([H])CC(=O)O[C@@]([H])(CC)CCC[C@]([H])(O[C@@]5([H])CC[C@]([H])(N(C)C)[C@@]([H])(C)O5)[C@@]([H])(C)C(=O)C4=C[C@@]3([H])[C@]2([H])C1)O[C@]1([H])O[C@@]([H])(C)[C@]([H])(OC)[C@@]([H])(OC)[C@@]1([H])OC,Spinosad,SmallMoleculeDrug,topical,1476.9373446239997,22,0,11.3649,222.43999999999994,18,22,0,0,1,0,0,0,0,0,0
258,vilazodone hydrochloride,NDA,2011,vilazodone,DB06684,approved,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,Vilazodone,SmallMoleculeDrug,oral,441.216475104,5,2,4.029580000000003,102.28999999999999,7,7,1,1,1,1,1,1,1,1,3
259,azilsartan medoxomil,NDA,2011,azilsartan medoxomil,DB08822,approved; investigational,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NOC(=O)N1)C(=CC=C2)C(=O)OCC1=C(C)OC(=O)O1,Azilsartan medoxomil,SmallMoleculeDrug,oral,568.1594137279999,11,1,4.705220000000004,155.58999999999997,9,12,0,0,1,1,0,1,1,1,2
260,roflumilast,NDA,2011,roflumilast,DB01656,approved,FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl,Roflumilast,SmallMoleculeDrug,oral,402.034954108,4,1,5.030900000000003,60.45,7,5,1,1,1,0,1,1,1,1,2
261,gadobutrol,NDA,2011,gadobutrol,DB06703,approved,OC[C@H](O)[C@H](CO)[N+]12CC[N+]3(CC([O-])=O)CC[N+]4(CC([O-])=O)CC[N+](CC([O-])=O)(CC1)[Gd-]234,Gadobutrol,SmallMoleculeDrug,intravenous,608.1550368282699,6,6,-3.9076999999999904,172.59,10,12,0,1,0,1,0,1,1,1,2
262,gabapentin enacarbil,NDA,2011,gabapentin enacarbil,DB08872,approved; investigational,CC(C)C(=O)OC(C)OC(=O)NCC1(CC(O)=O)CCCCC1,Gabapentin enacarbil,SmallMoleculeDrug,oral,329.18383758400006,5,2,2.6830000000000007,101.93,7,7,1,1,1,1,1,1,1,1,3
263,abiraterone acetate,NDA,2011,abiraterone,DB05812,approved,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,Abiraterone,SmallMoleculeDrug,oral,349.240564612,2,1,5.398600000000005,33.120000000000005,1,3,1,1,1,0,1,1,1,1,2
264,linagliptin,NDA,2011,linagliptin,DB08882,approved,CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=C(C=CC=C3)C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1,Linagliptin,SmallMoleculeDrug,oral,472.2335221360001,10,1,1.1474199999999997,116.85999999999999,4,11,1,1,1,1,1,1,1,1,3
265,boceprevir,NDA,2011,boceprevir,DB08873,approved; withdrawn,[H][C@]12CN([C@H](C(=O)NC(CC3CCC3)C(=O)C(N)=O)[C@@]1([H])C2(C)C)C(=O)[C@@H](NC(=O)NC(C)(C)C)C(C)(C)C,Boceprevir,SmallMoleculeDrug,oral,519.34206954,5,4,1.7112000000000012,150.7,8,9,0,1,1,1,0,1,1,1,2
266,rilpivirine,NDA,2011,rilpivirine,DB08864,approved,CC1=CC(\C=C\C#N)=CC(C)=C1NC1=CC=NC(NC2=CC=C(C=C2)C#N)=N1,Rilpivirine,SmallMoleculeDrug,oral,366.159294576,6,2,4.989100000000003,97.42,5,8,1,1,1,1,1,1,1,1,3
267,telaprevir,NDA,2011,telaprevir,DB05521,approved; withdrawn,[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=NC=CN=C1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1,Telaprevir,SmallMoleculeDrug,oral,679.4057324160001,8,4,2.445900000000002,179.56,13,12,0,1,1,1,0,0,1,1,1
268,fidaxomicin,NDA,2011,fidaxomicin,DB08874,approved,[H][C@@]1(O[C@@H]2[C@@H](CC)\C=C(C)\[C@@H](O)C\C=C\C=C(CO[C@@H]3O[C@H](C)[C@@H](OC(=O)C4=C(CC)C(Cl)=C(O)C(Cl)=C4O)[C@H](O)[C@@H]3OC)\C(=O)O[C@@H](C\C=C(/C)\C=C2/C)[C@@H](C)O)OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]1O,Fidaxomicin,SmallMoleculeDrug,oral,1056.4252208880002,18,7,6.234400000000011,266.6599999999999,13,25,0,0,0,0,0,0,0,0,0
269,ezogabine,NDA,2011,ezogabine,DB04953,approved; investigational,CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1,Ezogabine,SmallMoleculeDrug,oral,303.138305036,4,3,3.588400000000002,76.38,5,7,1,1,1,1,1,1,1,1,3
270,indacaterol,NDA,2011,indacaterol,DB05039,approved,CCC1=C(CC)C=C2CC(CC2=C1)NC[C@H](O)C1=C2C=CC(=O)NC2=C(O)C=C1,Indacaterol,SmallMoleculeDrug,oral inhalation,392.209992756,4,4,3.148900000000001,85.35000000000001,6,8,1,1,1,1,1,1,1,1,3
271,rivaroxaban,NDA,2011,rivaroxaban,DB06228,approved,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,Rivaroxaban,SmallMoleculeDrug,oral,435.065569356,6,1,2.5199,88.18,5,7,1,1,1,1,1,1,1,1,3
272,ticagrelor,NDA,2011,ticagrelor,DB08816,approved,CCCSC1=NC2=C(N=NN2[C@@H]2C[C@H](OCCO)[C@@H](O)[C@H]2O)C(N[C@@H]2C[C@H]2C2=CC(F)=C(F)C=C2)=N1,Ticagrelor,SmallMoleculeDrug,oral,522.186080816,11,4,2.013699999999999,138.44,10,15,0,0,1,1,1,1,0,1,3
273,vemurafenib,NDA,2011,vemurafenib,DB08881,approved,CCCS(=O)(=O)NC1=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C(F)C=C1,Vemurafenib,SmallMoleculeDrug,oral,489.072546556,4,2,5.544200000000004,91.92,7,6,1,1,1,0,1,1,1,1,2
274,icatibant,NDA,2011,icatibant,DB06196,approved; investigational,[H][C@]12C[C@]([H])(N(C(=O)[C@@]3([H])CC4=C(CN3C(=O)[C@H](CO)NC(=O)[C@H](CC3=CC=CS3)NC(=O)CNC(=O)[C@]3([H])C[C@@H](O)CN3C(=O)[C@@H]3CCCN3C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](N)CCCNC(N)=N)C=CC=C4)[C@@]1([H])CCCC2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O,Icatibant,SmallMoleculeDrug,subcutaneous,1303.6607949079994,17,18,-4.3939900000000245,516.2199999999999,30,35,0,0,0,1,0,0,0,0,1
275,crizotinib,NDA,2011,crizotinib,DB08865,approved,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,SmallMoleculeDrug,oral,449.118543904,6,2,5.0377000000000045,77.99000000000001,5,8,1,1,1,0,1,1,1,1,2
276,deferiprone,NDA,2011,deferiprone,DB08826,approved,CN1C=CC(=O)C(O)=C1C,Deferiprone,SmallMoleculeDrug,oral,139.063328528,3,1,0.3993199999999999,42.230000000000004,0,4,1,1,1,1,1,1,1,1,3
277,clobazam,NDA,2011,clobazam,DB00349,approved; illicit,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,Clobazam,SmallMoleculeDrug,oral,300.066555336,2,0,3.3712000000000018,40.620000000000005,1,2,1,1,1,1,1,1,1,1,3
278,ruxolitinib,NDA,2011,ruxolitinib,DB08877,approved,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,Ruxolitinib,SmallMoleculeDrug,oral topical,306.15929457600004,5,1,3.466380000000002,83.17999999999999,4,6,1,1,1,1,1,1,1,1,3
279,ingenol mebutate,NDA,2012,ingenol mebutate,DB05013,approved,[H][C@@]12C[C@@H](C)[C@]34C=C(C)[C@H](OC(=O)C(\C)=C/C)[C@@]3(O)[C@H](O)C(CO)=C[C@@]([H])(C4=O)[C@]1([H])C2(C)C,Ingenol mebutate,SmallMoleculeDrug,topical,430.235538808,6,3,2.3323,104.06,3,9,1,1,1,1,1,1,1,1,3
280,axitinib,NDA,2012,axitinib,DB06626,approved; investigational,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Axitinib,SmallMoleculeDrug,oral,386.120132196,4,2,4.639100000000003,70.67,5,6,1,1,1,1,1,1,1,1,3
281,vismodegib,NDA,2012,vismodegib,DB08828,approved; investigational,CS(=O)(=O)C1=CC(Cl)=C(C=C1)C(=O)NC1=CC=C(Cl)C(=C1)C1=CC=CC=N1,Vismodegib,SmallMoleculeDrug,oral,420.0102186680001,4,1,4.711200000000003,76.13,4,5,1,1,1,1,1,1,1,1,3
282,ivacaftor,NDA,2012,ivacaftor,DB08820,approved,CC(C)(C)C1=CC(=C(O)C=C1NC(=O)C1=CNC2=CC=CC=C2C1=O)C(C)(C)C,Ivacaftor,SmallMoleculeDrug,oral,392.209992756,3,3,5.081000000000004,82.19,2,6,1,1,1,0,1,1,1,1,2
283,tafluprost,NDA,2012,tafluprost,DB08819,approved,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,Tafluprost,SmallMoleculeDrug,ophthalmic,452.237430628,5,2,4.683000000000004,75.99000000000001,12,7,1,1,1,1,1,0,1,1,2
284,avanafil,NDA,2012,avanafil,DB06237,approved,COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N2CCC[C@H]2CO)C(=O)NCC2=NC=CC=N2)C=C1,Avanafil,SmallMoleculeDrug,oral,483.178565372,9,3,2.4318,125.39000000000001,9,12,1,1,1,1,1,1,1,1,3
285,lorcaserin hydrochloride,NDA,2012,lorcaserin,DB04871,approved,C[C@H]1CNCCC2=CC=C(Cl)C=C12,Lorcaserin,SmallMoleculeDrug,oral,195.081477128,1,1,2.589200000000001,12.03,0,2,1,1,1,1,1,1,1,1,3
286,mirabegron,NDA,2012,mirabegron,DB08893,approved,NC1=NC(CC(=O)NC2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2)=CS1,Mirabegron,SmallMoleculeDrug,oral,396.161997008,6,4,2.7722000000000007,100.27,9,10,1,1,1,1,1,1,1,1,3
287,carfilzomib,NDA,2012,carfilzomib,DB08889,approved; investigational,CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,Carfilzomib,SmallMoleculeDrug,intravenous,719.4257991640001,8,4,2.583500000000007,158.47,20,12,0,1,1,1,0,0,1,1,1
288,aclidinium bromide,NDA,2012,aclidinium,DB08897,approved,OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1,Aclidinium,SmallMoleculeDrug,inhalation,484.1610768600901,6,1,4.666800000000004,55.760000000000005,9,7,1,1,1,1,1,1,1,1,3
289,linaclotide,NDA,2012,linaclotide,DB08890,approved,[H][C@]1(CSSC[C@]2([H])NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CSSC[C@H](N)C(=O)N3)NC2=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)NCC(=O)N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O,Linaclotide,SmallMoleculeDrug,oral,1525.389920547999,26,19,-5.939200000000021,573.9099999999999,13,45,0,0,0,1,0,0,0,0,1
290,enzalutamide,NDA,2012,enzalutamide,DB08899,approved,CNC(=O)C1=C(F)C=C(C=C1)N1C(=S)N(C(=O)C1(C)C)C1=CC=C(C#N)C(=C1)C(F)(F)F,Enzalutamide,SmallMoleculeDrug,oral,464.093009632,4,1,3.992480000000003,76.44,3,5,1,1,1,1,1,1,1,1,3
291,bosutinib,NDA,2012,bosutinib,DB06616,approved,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,Bosutinib,SmallMoleculeDrug,oral,529.164745148,8,1,5.190380000000005,82.88,9,9,0,1,1,0,1,1,1,1,2
292,teriflunomide,NDA,2012,teriflunomide,DB08880,approved,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,Teriflunomide,SmallMoleculeDrug,oral,270.061612188,3,2,2.99948,73.11999999999999,2,5,1,1,1,1,1,1,1,1,3
293,regorafenib,NDA,2012,regorafenib,DB08896,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Regorafenib,SmallMoleculeDrug,oral,482.0768809000001,4,3,5.688800000000002,92.35000000000001,5,7,1,1,1,0,1,1,1,1,2
294,perampanel,NDA,2012,perampanel,DB08883,approved,O=C1N(C=C(C=C1C1=CC=CC=C1C#N)C1=NC=CC=C1)C1=CC=CC=C1,Perampanel,SmallMoleculeDrug,oral,349.1215121,4,0,4.438180000000003,58.68,3,4,1,1,1,1,1,1,1,1,3
295,tofacitinib,NDA,2012,tofacitinib,DB08895,approved; investigational,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,Tofacitinib,SmallMoleculeDrug,oral,312.16985926,5,1,1.5447799999999998,88.91,3,6,1,1,1,1,1,1,1,1,3
296,cabozantinib,NDA,2012,cabozantinib,DB08875,approved; investigational,COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2,Cabozantinib,SmallMoleculeDrug,oral,501.169999088,6,2,5.540800000000004,98.78,8,8,0,1,1,0,1,1,1,1,2
297,pasireotide,NDA,2012,pasireotide,DB06663,approved,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1,Pasireotide,SmallMoleculeDrug,instramuscular,1046.501423692,11,9,3.368500000000012,281.19999999999993,17,20,0,0,0,1,0,0,0,0,1
298,ponatinib,NDA,2012,ponatinib,DB08901,approved; investigational,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1,Ponatinib,SmallMoleculeDrug,oral,532.219844144,6,1,4.456020000000003,65.77,4,7,0,1,1,1,1,1,1,1,3
299,lomitapide,NDA,2012,lomitapide,DB08827,approved; investigational,FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C2=C(C=CC=C2)C2=CC=C(C=C2)C(F)(F)F)C2=CC=CC=C2C2=CC=CC=C12,Lomitapide,SmallMoleculeDrug,oral,693.278996744,3,2,8.382100000000005,61.440000000000005,10,5,0,1,1,0,1,1,1,1,2
300,apixaban,NDA,2012,apixaban,DB06605,approved,COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O,Apixaban,SmallMoleculeDrug,oral,459.19065428,6,1,2.699600000000001,110.75999999999999,5,7,1,1,1,1,1,1,1,1,3
301,bedaquiline,NDA,2012,bedaquiline,DB08903,approved,COC1=NC2=C(C=C(Br)C=C2)C=C1[C@@H](C1=CC=CC=C1)[C@@](O)(CCN(C)C)C1=CC=CC2=C1C=CC=C2,Bedaquiline,SmallMoleculeDrug,oral,554.156890332,4,1,7.1305000000000085,45.59,8,5,0,1,1,0,1,1,1,1,2
302,alogliptin,NDA,2013,alogliptin,DB06203,approved,CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=C(C=CC=C2)C#N)C1=O,Alogliptin,SmallMoleculeDrug,oral,339.16952491200004,7,1,0.3944800000000006,97.05000000000001,3,8,1,1,1,1,1,1,1,1,3
303,pomalidomide,NDA,2013,pomalidomide,DB08910,approved,NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Pomalidomide,SmallMoleculeDrug,oral,273.074955832,5,2,-0.3299999999999998,109.57,1,7,1,1,1,1,1,1,1,1,3
304,ospemifene,NDA,2013,ospemifene,DB04938,approved; investigational,OCCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,Ospemifene,SmallMoleculeDrug,oral,378.138657656,2,1,5.645700000000005,29.46,8,3,1,1,1,0,1,1,1,1,2
305,canagliflozin,NDA,2013,canagliflozin,DB08907,approved,[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC=C(C)C(CC2=CC=C(S2)C2=CC=C(F)C=C2)=C1,Canagliflozin,SmallMoleculeDrug,oral,444.1406731200001,6,4,2.968320000000001,90.15,5,10,1,1,1,1,1,1,1,1,3
306,dabrafenib,NDA,2013,dabrafenib,DB08912,approved; investigational,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1,Dabrafenib,SmallMoleculeDrug,oral,519.10105154,7,2,5.364900000000004,110.85999999999999,5,9,0,1,1,0,1,1,1,1,2
307,trametinib,NDA,2013,trametinib,DB08911,approved,CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=CC=C(I)C=C1F)C1=CC(NC(C)=O)=CC=C1,Trametinib,SmallMoleculeDrug,oral,615.077880436,8,2,3.940120000000002,107.13,5,10,0,1,1,1,1,1,1,1,3
308,afatinib,NDA,2013,afatinib,DB08916,approved,CN(C)C\C=C\C(=O)NC1=C(O[C@H]2CCOC2)C=C2N=CN=C(NC3=CC(Cl)=C(F)C=C3)C2=C1,Afatinib,SmallMoleculeDrug,oral,485.16299556000007,7,2,4.389900000000003,88.61000000000001,8,9,1,1,1,1,1,1,1,1,3
309,dolutegravir,NDA,2013,dolutegravir,DB08930,approved,[H][C@]12CN3C=C(C(=O)NCC4=CC=C(F)C=C4F)C(=O)C(O)=C3C(=O)N1[C@H](C)CCO2,Dolutegravir,SmallMoleculeDrug,oral,419.129277148,6,2,1.3527999999999998,100.87,3,8,1,1,1,1,1,1,1,1,3
310,vortioxetine,NDA,2013,vortioxetine,DB09068,approved; investigational,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Vortioxetine,SmallMoleculeDrug,oral,298.150369704,3,1,3.8642400000000015,15.27,3,4,1,1,1,1,1,1,1,1,3
311,riociguat,NDA,2013,riociguat,DB08931,approved,COC(=O)N(C)C1=C(N)N=C(N=C1N)C1=NN(CC2=C(F)C=CC=C2)C2=C1C=CC=N2,Riociguat,SmallMoleculeDrug,oral,422.161500068,9,2,2.4426999999999994,138.07,4,11,1,1,1,1,1,1,1,1,3
312,macitentan,NDA,2013,macitentan,DB08932,approved,CCCNS(=O)(=O)NC1=C(C(OCCOC2=NC=C(Br)C=N2)=NC=N1)C1=CC=C(Br)C=C1,Macitentan,SmallMoleculeDrug,oral,585.96334832,8,2,3.572700000000002,128.22000000000003,11,10,0,1,1,1,1,0,1,1,2
313,eslicarbazepine acetate,NDA,2013,eslicarbazepine,DB14575,approved,NC(=O)N1C2=C(C[C@H](O)C3=C1C=CC=C3)C=CC=C2,Eslicarbazepine,SmallMoleculeDrug,oral,254.105527688,2,2,2.492900000000001,66.56,0,4,1,1,1,1,1,1,1,1,3
314,ibrutinib,NDA,2013,ibrutinib,DB09053,approved,NC1=NC=NC2=C1C(=NN2[C@@H]1CCCN(C1)C(=O)C=C)C1=CC=C(OC2=CC=CC=C2)C=C1,Ibrutinib,SmallMoleculeDrug,oral,440.1960740079999,7,1,4.217300000000003,99.16000000000001,5,8,1,1,1,1,1,1,1,1,3
315,luliconazole,NDA,2013,luliconazole,DB08933,approved,ClC1=CC(Cl)=C(C=C1)[C@@H]1CS\C(S1)=C(\C#N)N1C=CN=C1,Luliconazole,SmallMoleculeDrug,topical,352.9614946480001,5,0,5.060880000000003,41.61,2,5,1,1,1,0,1,1,1,1,2
316,simeprevir,NDA,2013,simeprevir,DB06290,approved,[H][C@]12C[C@]1(NC(=O)[C@]1([H])C[C@H](C[C@@]1([H])C(=O)N(C)CCCC\C=C/2)OC1=CC(=NC2=C1C=CC(OC)=C2C)C1=NC(=CS1)C(C)C)C(=O)NS(=O)(=O)C1CC1,Simeprevir,SmallMoleculeDrug,oral,749.2916908440001,10,2,5.254120000000005,156.89,8,12,0,1,1,0,0,1,1,1,1
317,sofosbuvir,NDA,2013,sofosbuvir,DB08934,approved,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,Sofosbuvir,SmallMoleculeDrug,oral,529.1625443579999,10,3,1.6565000000000003,158.17999999999995,10,13,0,1,1,1,0,1,0,0,2
318,dapagliflozin,NDA,2014,dapagliflozin,DB06292,approved,CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1,Dapagliflozin,SmallMoleculeDrug,oral,408.1339661999999,6,4,1.8443999999999987,99.38000000000001,6,10,1,1,1,1,1,1,1,1,3
319,tasimelteon,NDA,2014,tasimelteon,DB09071,approved; investigational,CCC(=O)NC[C@@H]1C[C@H]1C1=CC=CC2=C1CCO2,Tasimelteon,SmallMoleculeDrug,oral,245.141578848,2,1,2.2512,38.33,4,3,1,1,1,1,1,1,1,1,3
320,droxidopa,NDA,2014,droxidopa,DB06262,approved; investigational,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,Droxidopa,SmallMoleculeDrug,oral,213.063722452,5,5,-0.4569000000000001,124.01000000000002,3,10,1,1,1,1,1,1,1,1,3
321,miltefosine,NDA,2014,miltefosine,DB09031,approved; investigational,CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C,Miltefosine,SmallMoleculeDrug,oral,408.32372203409,3,1,6.307500000000008,55.760000000000005,20,4,1,1,1,0,1,0,1,1,1
322,apremilast,NDA,2014,apremilast,DB05676,approved; investigational,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,Apremilast,SmallMoleculeDrug,oral,460.130422108,7,1,2.4342000000000006,119.07999999999998,8,8,1,1,1,1,1,1,1,1,3
323,ceritinib,NDA,2014,ceritinib,DB09063,approved,CC(C)OC1=C(NC2=NC=C(Cl)C(N2)=NC2=CC=CC=C2S(=O)(=O)C(C)C)C=C(C)C(=C1)C1CCNCC1,Ceritinib,SmallMoleculeDrug,oral,557.222738692,7,3,5.783820000000005,108.47,8,10,0,1,1,0,1,1,1,1,2
324,vorapaxar,NDA,2014,vorapaxar,DB09030,approved,[H][C@@]12C[C@]3([H])C[C@@H](CC[C@@]3([H])[C@H](\C=C\C3=CC=C(C=N3)C3=CC(F)=CC=C3)[C@]1([H])[C@@H](C)OC2=O)NC(=O)OCC,Vorapaxar,SmallMoleculeDrug,oral,492.2424357559999,5,1,5.629500000000006,77.52,5,6,1,1,1,0,1,1,1,1,2
325,efinaconazole,NDA,2014,efinaconazole,DB09040,approved,C[C@@H](N1CCC(=C)CC1)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,Efinaconazole,SmallMoleculeDrug,topical,348.176167764,5,1,2.4846000000000004,54.18,5,6,1,1,1,1,1,1,1,1,3
326,tedizolid phosphate,NDA,2014,tedizolid,DB14569,approved; investigational,CN1N=NC(=N1)C1=NC=C(C=C1)C1=C(F)C=C(C=C1)N1C[C@H](CO)OC1=O,Tedizolid,SmallMoleculeDrug,oral intravenous,370.11896655999993,8,1,1.3957,106.26000000000002,4,9,1,1,1,1,1,1,1,1,3
327,belinostat,NDA,2014,belinostat,DB05015,approved; investigational,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1,Belinostat,SmallMoleculeDrug,intravenous,318.067427928,4,3,2.006,95.5,5,7,1,1,1,1,1,1,1,1,3
328,tavaborole,NDA,2014,tavaborole,DB09041,approved; investigational,OB1OCC2=CC(F)=CC=C12,Tavaborole,SmallMoleculeDrug,topical,152.044488052,2,1,0.0433999999999999,29.46,0,3,1,1,1,1,1,1,1,1,3
329,idelalisib,NDA,2014,idelalisib,DB09054,approved,[H][C@@](CC)(NC1=NC=NC2=C1N=CN2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1,Idelalisib,SmallMoleculeDrug,oral,415.155686416,7,2,3.7543000000000015,101.38000000000002,5,9,1,1,1,1,1,1,1,1,3
330,olodaterol,NDA,2014,olodaterol,DB09080,approved,COC1=CC=C(CC(C)(C)NC[C@H](O)C2=C3OCC(=O)NC3=CC(O)=C2)C=C1,Olodaterol,SmallMoleculeDrug,inhalation,386.184171932,6,4,2.3759999999999994,100.05,7,10,1,1,1,1,1,1,1,1,3
331,empagliflozin,NDA,2014,empagliflozin,DB09038,approved,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(O[C@H]3CCOC3)C=C2)=C1,Empagliflozin,SmallMoleculeDrug,oral,450.144530884,7,4,1.6133999999999995,108.61000000000001,6,11,1,1,1,1,1,1,1,1,3
332,oritavancin diphosphate,NDA,2014,oritavancin,DB04911,approved; investigational,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(NCC5=CC=C(C=C5)C5=CC=C(Cl)C=C5)[C@@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O[C@H]1C[C@](C)(N)[C@@H](O)[C@H](C)O1)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,Oritavancin,SmallMoleculeDrug,intravenous,1790.564106263999,28,20,4.495200000000016,560.98,19,48,0,0,0,1,0,0,0,0,1
333,suvorexant,NDA,2014,suvorexant,DB09034,approved; investigational,[H][C@@]1(C)CCN(CCN1C(=O)C1=C(C=CC(C)=C1)N1N=CC=N1)C1=NC2=C(O1)C=CC(Cl)=C2,Suvorexant,SmallMoleculeDrug,oral,450.15710165600007,7,0,4.111320000000004,80.29,3,7,1,1,1,1,1,1,1,1,3
334,eliglustat,NDA,2014,eliglustat,DB09039,approved,CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)C1=CC=C2OCCOC2=C1,Eliglustat,SmallMoleculeDrug,oral,404.26750763199993,5,2,3.4323000000000023,71.03000000000002,11,7,1,1,1,1,1,0,1,1,2
335,naloxegol,NDA,2014,naloxegol,DB09049,approved,COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC=C)[C@H]1O5,Naloxegol,SmallMoleculeDrug,oral,651.3618615159999,12,2,1.863500000000004,126.77000000000002,24,14,0,0,1,1,1,0,0,1,2
336,pirfenidone,NDA,2014,pirfenidone,DB04951,approved; investigational,CC1=CN(C(=O)C=C1)C1=CC=CC=C1,Pirfenidone,SmallMoleculeDrug,oral,185.084063972,2,0,2.1459200000000003,22.0,1,2,1,1,1,1,1,1,1,1,3
337,nintedanib,NDA,2014,nintedanib,DB09079,approved,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1,Nintedanib,SmallMoleculeDrug,oral,539.2532545360001,7,2,3.6159000000000026,94.21999999999997,7,9,0,1,1,1,1,1,1,1,3
338,finafloxacin,NDA,2014,finafloxacin,DB09047,approved; investigational,[H][C@]12CN(C[C@]1([H])OCCN2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1C#N)C(O)=O,Finafloxacin,SmallMoleculeDrug,auricular,398.139033308,7,2,1.2223799999999998,107.59,3,9,1,1,1,1,1,1,1,1,3
339,olaparib,NDA,2014,olaparib,DB09074,approved,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1,Olaparib,SmallMoleculeDrug,oral,434.1754188160001,4,1,2.3473999999999995,86.37,4,5,1,1,1,1,1,1,1,1,3
340,peramivir,NDA,2014,peramivir,DB06614,approved; investigational,[H][C@@]1([C@@H](NC(C)=O)C(CC)CC)[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O,Peramivir,SmallMoleculeDrug,intravenous,328.21105537599993,4,6,-0.1394299999999977,148.52999999999997,7,10,1,1,0,1,0,1,1,1,2
341,edoxaban tosylate,NDA,2015,edoxaban,DB09075,approved,CN(C)C(=O)[C@H]1CC[C@H](NC(=O)C(=O)NC2=NC=C(Cl)C=C2)[C@@H](C1)NC(=O)C1=NC2=C(CN(C)CC2)S1,Edoxaban,SmallMoleculeDrug,oral,547.1768511200002,8,3,1.2895999999999996,136.63,5,11,0,1,1,1,1,1,1,1,3
342,palbociclib,NDA,2015,palbociclib,DB09073,approved; investigational,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,Palbociclib,SmallMoleculeDrug,oral,447.238273168,9,2,2.965820000000001,105.03999999999999,5,11,1,1,1,1,1,1,1,1,3
343,lenvatinib,NDA,2015,lenvatinib,DB09078,approved; investigational,COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O,Lenvatinib,SmallMoleculeDrug,oral,426.109482768,5,3,4.071900000000002,115.57,6,8,1,1,1,1,1,1,1,1,3
344,panobinostat,NDA,2015,panobinostat,DB06603,approved; investigational,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,Panobinostat,SmallMoleculeDrug,oral,349.17902697600005,3,4,3.3272200000000014,77.15,7,7,1,1,1,1,1,1,1,1,3
345,isavuconazonium sulfate,NDA,2015,isavuconazonium,DB06636,approved; investigational,[H]C(C)(OC(=O)N(C)C1=C(COC(=O)CNC)C=CC=N1)[N+]1=CN(C[C@](O)(C2=C(F)C=CC(F)=C2)[C@@]([H])(C)C2=NC(=CS2)C2=CC=C(C=C2)C#N)N=C1,Isavuconazonium,SmallMoleculeDrug,oral intravenous,717.2413700800901,12,2,4.584580000000004,159.37,13,14,0,0,1,1,0,0,0,0,1
346,cholic acid,NDA,2015,cholic acid,DB02659,approved,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C,Cholic Acid,SmallMoleculeDrug,oral,408.28757438,4,4,3.4487000000000023,97.99000000000001,4,8,1,1,1,1,1,1,1,1,3
347,ivabradine,NDA,2015,ivabradine,DB09083,approved,COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1,Ivabradine,SmallMoleculeDrug,oral,468.2624222519999,6,0,3.3100000000000014,60.470000000000006,10,6,1,1,1,1,1,1,1,1,3
348,deoxycholic acid,NDA,2015,deoxycholic acid,DB03619,approved,[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C,Deoxycholic acid,SmallMoleculeDrug,subcutaneous,392.29265976,3,3,4.477900000000004,77.76,4,6,1,1,1,1,1,1,1,1,3
349,eluxadoline,NDA,2015,eluxadoline,DB09272,approved; investigational,COC1=CC=C(CN([C@@H](C)C2=NC(=CN2)C2=CC=CC=C2)C(=O)[C@@H](N)CC2=C(C)C=C(C=C2C)C(N)=O)C=C1C(O)=O,Eluxadoline,SmallMoleculeDrug,oral,569.26381922,6,4,4.159040000000002,164.62999999999997,11,10,0,1,1,1,0,0,1,1,1
350,cangrelor,NDA,2015,cangrelor,DB06441,approved,CSCCNC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC(SCCC(F)(F)F)=N1,Cangrelor,SmallMoleculeDrug,intravenous,774.9483131499999,15,7,2.850500000000002,255.90999999999997,15,22,0,0,0,1,0,0,0,0,1
351,brexpiprazole,NDA,2015,brexpiprazole,DB09128,approved; investigational,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1,Brexpiprazole,SmallMoleculeDrug,oral,433.182398104,5,1,4.724000000000005,48.57000000000001,7,6,1,1,1,1,1,1,1,1,3
352,sonidegib,NDA,2015,sonidegib,DB09143,approved; investigational,[H][C@]1(C)CN(C[C@@]([H])(C)O1)C1=CC=C(NC(=O)C2=CC=CC(=C2C)C2=CC=C(OC(F)(F)F)C=C2)C=N1,Sonidegib,SmallMoleculeDrug,oral,485.192626352,5,1,5.821520000000005,63.69,5,6,1,1,1,0,1,1,1,1,2
353,daclatasvir,NDA,2015,daclatasvir,DB09102,approved; investigational,COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1=NC=C(N1)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CN=C(N1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C,Daclatasvir,SmallMoleculeDrug,oral,738.3853313200001,8,4,6.222000000000005,174.64,11,12,0,1,1,0,0,0,1,1,0
354,flibanserin,NDA,2015,flibanserin,DB04908,approved; investigational,FC(F)(F)C1=CC(=CC=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1,Flibanserin,SmallMoleculeDrug,oral,390.166745952,4,1,3.170600000000002,44.269999999999996,4,5,1,1,1,1,1,1,1,1,3
355,rolapitant,NDA,2015,rolapitant,DB09291,approved; investigational,C[C@@H](OC[C@]1(CC[C@]2(CCC(=O)N2)CN1)C1=CC=CC=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,Rolapitant,SmallMoleculeDrug,oral,500.189847392,3,2,5.729500000000004,50.36,5,5,0,1,1,0,1,1,1,1,2
356,uridine triacetate,NDA,2015,uridine triacetate,DB09144,approved; investigational,CC(=O)OC[C@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)N1C=CC(=O)NC1=O,Uridine triacetate,SmallMoleculeDrug,oral,370.101230156,10,1,-1.1394999999999986,142.98999999999998,5,11,1,1,1,1,0,1,1,1,2
357,cariprazine,NDA,2015,cariprazine,DB06016,approved; investigational,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1,Cariprazine,SmallMoleculeDrug,oral,426.195317004,3,1,4.335500000000003,38.82000000000001,5,4,1,1,1,1,1,1,1,1,3
358,aripiprazole lauroxil,NDA,2015,aripiprazole lauroxil,DB14185,approved; investigational,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12,Aripiprazole lauroxil,SmallMoleculeDrug,intramuscular,659.3256624720001,6,0,8.675400000000005,62.32000000000001,19,6,0,1,1,0,1,0,1,1,1
359,trabectedin,NDA,2015,trabectedin,DB05109,approved; investigational,[H][C@@]12[C@@H]3SC[C@]4(NCCC5=C4C=C(OC)C(O)=C5)C(=O)OC[C@H](N1[C@@H](O)[C@@H]1CC4=CC(C)=C(OC)C(O)=C4[C@H]2N1C)C1=C2OCOC2=C(C)C(OC(C)=O)=C31,Trabectedin,SmallMoleculeDrug,intravenous,761.261830196,15,4,3.413240000000002,168.71999999999997,3,19,0,0,1,1,0,1,0,0,2
360,cobimetinib,NDA,2015,cobimetinib,DB05239,approved; investigational,OC1(CN(C1)C(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(F)=C(F)C=C1)[C@@H]1CCCCN1,Cobimetinib,SmallMoleculeDrug,oral,531.063059572,4,3,3.781100000000002,64.6,4,7,0,1,1,1,1,1,1,1,3
361,osimertinib,NDA,2015,osimertinib,DB09330,approved,COC1=C(NC2=NC=CC(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C,Osimertinib,SmallMoleculeDrug,oral,499.2695732960001,8,2,4.509800000000003,87.54999999999998,10,10,1,1,1,1,1,1,1,1,3
362,ixazomib,NDA,2015,ixazomib,DB09570,approved; investigational,CC(C)C[C@H](NC(=O)CNC(=O)C1=CC(Cl)=CC=C1Cl)B(O)O,Ixazomib,SmallMoleculeDrug,oral,360.081492848,4,4,1.2660999999999991,98.66000000000001,7,8,1,1,1,1,1,1,1,1,3
363,alectinib,NDA,2015,alectinib,DB11363,approved; investigational,CCC1=CC2=C(C=C1N1CCC(CC1)N1CCOCC1)C(C)(C)C1=C(C3=CC=C(C=C3N1)C#N)C2=O,Alectinib,SmallMoleculeDrug,oral,482.268176328,5,1,4.773280000000004,72.36,3,6,1,1,1,1,1,1,1,1,3
364,sugammadex,NDA,2015,sugammadex,DB06206,approved,O[C@@H]1[C@@H](O)[C@@H]2O[C@H]3O[C@H](CSCCC(O)=O)[C@@H](O[C@H]4O[C@H](CSCCC(O)=O)[C@@H](O[C@H]5O[C@H](CSCCC(O)=O)[C@@H](O[C@H]6O[C@H](CSCCC(O)=O)[C@@H](O[C@H]7O[C@H](CSCCC(O)=O)[C@@H](O[C@H]8O[C@H](CSCCC(O)=O)[C@@H](O[C@H]9O[C@H](CSCCC(O)=O)[C@@H](O[C@H]1O[C@@H]2CSCCC(O)=O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,Sugammadex,SmallMoleculeDrug,intravenous,2000.408873343998,48,24,-7.681600000000015,769.7600000000003,40,72,0,0,0,1,0,0,0,0,1
365,selexipag,NDA,2015,selexipag,DB11362,approved,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)C1=NC(C2=CC=CC=C2)=C(N=C1)C1=CC=CC=C1,Selexipag,SmallMoleculeDrug,oral intravenous,496.214426504,7,1,3.8980000000000032,101.49000000000001,12,8,1,1,1,1,1,0,1,1,2
366,lesinurad,NDA,2015,lesinurad,DB11560,approved; investigational,OC(=O)CSC1=NN=C(Br)N1C1=CC=C(C2CC2)C2=C1C=CC=C2,Lesinurad,SmallMoleculeDrug,oral,402.999009788,5,1,4.2371000000000025,68.00999999999999,5,6,1,1,1,1,1,1,1,1,3
367,brivaracetam,NDA,2016,brivaracetam,DB05541,approved; investigational,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1,Brivaracetam,SmallMoleculeDrug,oral intravenous,212.15247788,2,1,0.8988999999999999,63.4,5,3,1,1,1,1,1,1,1,1,3
368,venetoclax,NDA,2016,venetoclax,DB11581,approved; investigational,CC1(C)CCC(CN2CCN(CC2)C2=CC=C(C(=O)NS(=O)(=O)C3=CC=C(NCC4CCOCC4)C(=C3)[N+]([O-])=O)C(OC3=CN=C4NC=CC4=C3)=C2)=C(C1)C1=CC=C(Cl)C=C1,Venetoclax,SmallMoleculeDrug,oral,867.3180956199999,11,3,8.659900000000006,172.03,13,14,0,0,1,0,0,0,0,0,0
369,pimavanserin,NDA,2016,pimavanserin,DB05316,approved; investigational,CC(C)COC1=CC=C(CNC(=O)N(CC2=CC=C(F)C=C2)C2CCN(C)CC2)C=C1,Pimavanserin,SmallMoleculeDrug,oral,427.263505548,3,1,4.6665000000000045,44.81,8,4,1,1,1,1,1,1,1,1,3
370,obeticholic acid,NDA,2016,obeticholic acid,DB05990,approved,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)[C@H](CC)[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,Obeticholic acid,SmallMoleculeDrug,oral,420.32395988799993,3,3,5.114000000000005,77.75999999999999,5,6,1,1,1,0,1,1,1,1,2
371,lifitegrast,NDA,2016,lifitegrast,DB11611,approved,CS(=O)(=O)C1=CC(C[C@H](NC(=O)C2=C(Cl)C3=C(CN(CC3)C(=O)C3=CC=C4C=COC4=C3)C=C2Cl)C(O)=O)=CC=C1,Lifitegrast,SmallMoleculeDrug,ophthalmic,614.0681274680001,6,2,4.767300000000004,133.99,7,8,0,1,1,1,1,1,1,1,3
372,crisaborole,NDA,2016,crisaborole,DB05219,approved; investigational,OB1OCC2=C1C=CC(OC1=CC=C(C=C1)C#N)=C2,Crisaborole,SmallMoleculeDrug,topical,251.07537358,4,1,1.56828,62.48,2,5,1,1,1,1,1,1,1,1,3
373,rucaparib,NDA,2016,rucaparib,DB12332,approved; investigational,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3,Rucaparib,SmallMoleculeDrug,oral,323.143390416,2,3,2.9793000000000003,56.919999999999995,3,5,1,1,1,1,1,1,1,1,3
374,plecanatide,NDA,2017,plecanatide,DB13170,approved; investigational,[H][C@@]12CSSC[C@H](NC(=O)CNC(=O)[C@@]([H])(NC(=O)[C@]([H])(CSSC[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC2=O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O,Plecanatide,SmallMoleculeDrug,oral,1680.625199447999,27,23,-8.14829999999998,718.13,28,50,0,0,0,1,0,0,0,0,1
375,etelcalcetide,NDA,2017,etelcalcetide,DB12865,approved; investigational,C[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](C)NC(=O)[C@@H](CSSC[C@H](N)C(O)=O)NC(C)=O)C(=O)N[C@H](CCCNC(N)=N)C(N)=O,Etelcalcetide,SmallMoleculeDrug,intravenous,1047.5290695360002,16,22,-7.228619999999994,557.7099999999998,36,38,0,0,0,1,0,0,0,0,1
376,deflazacort,NDA,2017,deflazacort,DB11921,approved; investigational,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@]([H])(O)C[C@]3(C)[C@@]1(N=C(C)O2)C(=O)COC(C)=O,Deflazacort,SmallMoleculeDrug,oral,441.215137712,7,1,2.563200000000001,102.26000000000002,3,8,1,1,1,1,1,1,1,1,3
377,telotristat ethyl,NDA,2017,telotristat ethyl,DB12095,approved; investigational,CCOC(=O)[C@@H](N)CC1=CC=C(C=C1)C1=NC(N)=NC(O[C@H](C2=CC=C(Cl)C=C2N2C=CC(C)=N2)C(F)(F)F)=C1,Telotristat ethyl,SmallMoleculeDrug,oral,574.1707010320001,9,2,4.988620000000003,131.17000000000002,9,11,0,1,1,1,1,1,1,1,3
378,ribociclib,NDA,2017,ribociclib,DB11730,approved; investigational,CN(C)C(=O)C1=CC2=CN=C(NC3=CC=C(C=N3)N3CCNCC3)N=C2N1C1CCCC1,Ribociclib,SmallMoleculeDrug,oral,434.25425758000006,8,2,2.7964,91.21000000000001,5,10,1,1,1,1,1,1,1,1,3
379,safinamide,NDA,2017,safinamide,DB06654,approved; investigational,C[C@H](NCC1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C(N)=O,Safinamide,SmallMoleculeDrug,oral,302.143056068,3,2,2.3681,64.35,7,5,1,1,1,1,1,1,1,1,3
380,naldemedine,NDA,2017,naldemedine,DB11691,approved; investigational,[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]5(O)CC(C(=O)NC(C)(C)C1=NC(=NO1)C1=CC=CC=C1)=C2O)=CC=C3O,Naldemedine,SmallMoleculeDrug,oral,570.2478348080001,9,4,3.4798000000000013,141.18,6,13,0,1,1,1,0,1,0,0,2
381,niraparib,NDA,2017,niraparib,DB11793,approved; investigational,NC(=O)C1=CC=CC2=CN(N=C12)C1=CC=C(C=C1)[C@@H]1CCCNC1,Niraparib,SmallMoleculeDrug,oral,320.16371126,4,2,2.5914,72.94,3,6,1,1,1,1,1,1,1,1,3
382,deutetrabenazine,NDA,2017,deutetrabenazine,DB12161,approved; investigational,[2H]C([2H])([2H])OC1=CC2=C(C=C1OC([2H])([2H])[2H])[C@@H]1CC(=O)[C@@H](CC(C)C)CN1CC2,Deutetrabenazine,SmallMoleculeDrug,oral,323.2367542,4,0,3.238100000000002,38.77,6,4,1,1,1,1,1,1,1,1,3
383,valbenazine,NDA,2017,valbenazine,DB11915,approved; investigational,COC1=C(OC)C=C2[C@H]3C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN3CCC2=C1,Valbenazine,SmallMoleculeDrug,oral,418.283157696,6,1,3.5641000000000025,74.02,7,7,1,1,1,1,1,1,1,1,3
384,midostaurin,NDA,2017,midostaurin,DB06595,approved; investigational,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1,Midostaurin,SmallMoleculeDrug,oral,570.22670544,6,1,5.906800000000007,77.73,3,7,0,1,1,0,1,1,1,1,2
385,brigatinib,NDA,2017,brigatinib,DB12267,approved; investigational,COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1,Brigatinib,SmallMoleculeDrug,oral,583.259137798,9,2,5.090000000000005,85.85999999999999,8,11,0,1,1,0,1,1,1,1,2
386,edaravone,NDA,2017,edaravone,DB12243,approved; investigational,CC1=NN(C(=O)C1)C1=CC=CC=C1,Edaravone,SmallMoleculeDrug,intravenous,174.07931294,2,0,1.7992,32.67,1,2,1,1,1,1,1,1,1,1,3
387,delafloxacin,NDA,2017,delafloxacin,DB11943,approved; investigational,NC1=NC(N2C=C(C(O)=O)C(=O)C3=CC(F)=C(N4CC(O)C4)C(Cl)=C23)=C(F)C=C1F,Delafloxacin,SmallMoleculeDrug,oral injection,440.049917204,7,3,1.9177,121.67999999999998,3,10,1,1,1,1,1,1,1,1,3
388,betrixaban,NDA,2017,betrixaban,DB12364,approved; investigational,COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC1=CC=C(Cl)C=N1,Betrixaban,SmallMoleculeDrug,oral,451.141117244,5,3,4.135170000000002,107.41000000000001,6,8,1,1,1,1,1,1,1,1,3
389,neratinib,NDA,2017,neratinib,DB11828,approved; investigational,CCOC1=C(NC(=O)\C=C\CN(C)C)C=C2C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C(C=NC2=C1)C#N,Neratinib,SmallMoleculeDrug,oral,556.198966468,8,2,5.932480000000006,112.4,11,10,0,1,1,0,1,0,1,1,1
390,enasidenib,NDA,2017,enasidenib,DB13874,approved; investigational,CC(C)(O)CNC1=NC(=NC(NC2=CC(=NC=C2)C(F)(F)F)=N1)C1=NC(=CC=C1)C(F)(F)F,Enasidenib,SmallMoleculeDrug,oral,473.13987748400007,8,3,4.292600000000002,108.74,6,11,1,1,1,1,1,1,1,1,3
391,benznidazole,NDA,2017,benznidazole,DB11989,approved; investigational,[O-][N+](=O)C1=NC=CN1CC(=O)NCC1=CC=CC=C1,Benznidazole,SmallMoleculeDrug,oral,260.090940244,5,1,1.1076999999999997,90.06,5,6,1,1,1,1,1,1,1,1,3
392,copanlisib,NDA,2017,copanlisib,DB12483,approved; investigational,COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21,Copanlisib,SmallMoleculeDrug,intravenous,480.2233513760001,11,2,0.661800000000002,139.79000000000002,7,13,1,0,1,1,1,1,0,1,3
393,secnidazole,NDA,2017,secnidazole,DB12834,approved,CC(O)CN1C(C)=NC=C1N(=O)=O,Secnidazole,SmallMoleculeDrug,oral,185.080041212,5,1,0.4805199999999999,81.19,3,6,1,1,1,1,1,1,1,1,3
394,abemaciclib,NDA,2017,abemaciclib,DB12001,approved; investigational,CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC(F)=C4N=C(C)N(C(C)C)C4=C3)N=C2)CC1,Abemaciclib,SmallMoleculeDrug,oral,506.271799464,8,1,4.936920000000004,75.0,7,9,0,1,1,1,1,1,1,1,3
395,acalabrutinib,NDA,2017,acalabrutinib,DB11703,approved; investigational,CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1,Acalabrutinib,SmallMoleculeDrug,oral,465.191322976,7,2,3.312600000000001,118.51,4,9,1,1,1,1,1,1,1,1,3
396,latanoprostene bunod,NDA,2017,latanoprostene bunod,DB11660,approved; investigational,O[C@H](CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)OCCCCO[N+]([O-])=O)CCC1=CC=CC=C1,Latanoprostene bunod,SmallMoleculeDrug,ophthalmic,507.283217272,8,3,3.7665000000000033,139.36,18,11,0,1,1,1,1,0,1,1,2
397,letermovir,NDA,2017,letermovir,DB12070,approved; investigational,COC1=CC=CC(=C1)N1CCN(CC1)C1=NC2=C(C=CC=C2F)[C@H](CC(O)=O)N1C1=CC(=CC=C1OC)C(F)(F)F,Letermovir,SmallMoleculeDrug,oral intravenous,572.204668256,7,1,5.707400000000005,77.84,6,8,0,1,1,0,1,1,1,1,2
398,semaglutide,NDA,2017,semaglutide,DB13928,approved; investigational,CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC1=CN=CN1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O,Semaglutide,SmallMoleculeDrug,subcutaneous oral,4111.115376892007,56,57,-11.627860000000226,1646.179999999999,149,113,0,0,0,1,0,0,0,0,1
399,ozenoxacin,NDA,2017,ozenoxacin,DB12924,approved; investigational,CNC1=NC=C(C=C1C)C1=CC=C2C(=O)C(=CN(C3CC3)C2=C1C)C(O)=O,Ozenoxacin,SmallMoleculeDrug,topical,363.158291532,5,2,3.7551400000000026,84.22,4,7,1,1,1,1,1,1,1,1,3
400,netarsudil,NDA,2017,netarsudil,DB13931,approved,CC1=CC(C)=C(C=C1)C(=O)OCC1=CC=C(C=C1)[C@@H](CN)C(=O)NC1=CC=C2C=NC=CC2=C1,Netarsudil,SmallMoleculeDrug,ophthalmic,453.2052417240001,5,2,4.889640000000004,94.31,7,7,1,1,1,1,1,1,1,1,3
401,ertugliflozin,NDA,2017,ertugliflozin,DB11827,approved; investigational,CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@]23OC[C@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)C=C1,Ertugliflozin,SmallMoleculeDrug,oral,436.1288808199999,7,4,1.3564999999999992,108.61000000000001,6,11,1,1,1,1,1,1,1,1,3
402,macimorelin,NDA,2017,macimorelin,DB13074,approved; investigational,CC(C)(N)C(=O)N[C@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@H](CC1=CNC2=CC=CC=C12)NC=O,Macimorelin,SmallMoleculeDrug,oral,474.23793882,4,6,1.8448,144.89999999999998,10,10,1,1,0,1,0,1,1,1,2
403,apalutamide,NDA,2018,apalutamide,DB11901,approved; investigational,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F,Apalutamide,SmallMoleculeDrug,oral,477.0882586000001,5,1,3.5315800000000026,89.33000000000001,3,6,1,1,1,1,1,1,1,1,3
404,fostamatinib disodium hexahydrate,NDA,2018,fostamatinib,DB12010,approved; investigational,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC,Fostamatinib,SmallMoleculeDrug,oral,580.148291262,12,4,3.094500000000002,186.71999999999997,10,16,0,0,1,1,0,1,0,0,2
405,lofexidine,NDA,2018,lofexidine,DB04948,approved; investigational,CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1,Lofexidine,SmallMoleculeDrug,oral,258.032668364,3,1,2.7624000000000004,33.62,3,4,1,1,1,1,1,1,1,1,3
406,avatrombopag,NDA,2018,avatrombopag,DB11995,approved; investigational,OC(=O)C1CCN(CC1)C1=C(Cl)C=C(C=N1)C(=O)NC1=NC(C2=CC(Cl)=CS2)=C(S1)N1CCN(CC1)C1CCCCC1,Avatrombopag,SmallMoleculeDrug,oral,648.1510863080001,9,2,6.581400000000007,101.89999999999999,7,11,0,1,1,0,1,1,1,1,2
407,baricitinib,NDA,2018,baricitinib,DB11817,approved; investigational,CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,Baricitinib,SmallMoleculeDrug,oral,371.11644378400007,7,1,1.09568,120.56,5,8,1,1,1,1,1,1,1,1,3
408,moxidectin,NDA,2018,moxidectin,DB11431,approved; investigational; vet_approved,[H][C@@]12OC\C3=C/C=C/[C@H](C)C\C(C)=C\C[C@]4([H])C[C@@]([H])(C[C@]5(C\C(=N/OC)[C@H](C)[C@H](O5)C(\C)=C\C(C)C)O4)OC(=O)[C@]([H])(C=C(C)[C@H]1O)[C@@]23O,Moxidectin,SmallMoleculeDrug,oral,639.377117656,9,2,5.728900000000008,116.04000000000002,3,11,0,1,1,0,1,1,1,1,2
409,plazomicin,NDA,2018,plazomicin,DB12615,approved; investigational,CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3OC(CNCCO)=CC[C@H]3N)[C@@H]2O)NC(=O)[C@@H](O)CCN)OC[C@]1(C)O,Plazomicin,SmallMoleculeDrug,intravenous,592.343191736,15,11,-5.361100000000004,269.28999999999996,13,26,0,0,0,1,0,0,0,0,1
410,cannabidiol,NDA,2018,cannabidiol,DB09061,approved; investigational,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1,Cannabidiol,SmallMoleculeDrug,oral,314.2245802,2,2,5.846500000000007,40.46,6,4,1,1,1,0,1,1,1,1,2
411,encorafenib,NDA,2018,encorafenib,DB11718,approved; investigational,COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C,Encorafenib,SmallMoleculeDrug,oral,539.151779244,9,3,3.908400000000002,140.13,9,12,0,1,1,1,0,1,1,1,2
412,binimetinib,NDA,2018,binimetinib,DB11967,approved; investigational,CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO,Binimetinib,SmallMoleculeDrug,oral,440.02955888,6,3,3.0113000000000016,88.41000000000001,6,9,1,1,1,1,1,1,1,1,3
413,tecovirimat,NDA,2018,tecovirimat,DB12020,approved; investigational,FC(F)(F)C1=CC=C(C=C1)C(=O)NN1C(=O)[C@H]2[C@H]([C@H]3C=C[C@@H]2[C@@H]2C[C@H]32)C1=O,Tecovirimat,SmallMoleculeDrug,oral,376.103477,3,1,2.4033000000000007,66.48,2,4,1,1,1,1,1,1,1,1,3
414,tafenoquine,NDA,2018,tafenoquine,DB06608,approved; investigational,COC1=CC(C)=C2C(OC3=CC=CC(=C3)C(F)(F)F)=C(OC)C=C(NC(C)CCCN)C2=N1,Tafenoquine,SmallMoleculeDrug,oral,463.2082764160001,6,2,5.910820000000005,78.63,9,8,1,1,1,0,1,1,1,1,2
415,ivosidenib,NDA,2018,ivosidenib,DB14568,approved; investigational,[H][C@@](N(C(=O)[C@]1([H])CCC(=O)N1C1=NC=CC(=C1)C#N)C1=CC(F)=CN=C1)(C(=O)NC1CC(F)(F)C1)C1=C(Cl)C=CC=C1,Ivosidenib,SmallMoleculeDrug,oral,582.1394009040001,6,1,4.324580000000003,119.29000000000002,7,7,0,1,1,1,1,1,1,1,3
416,elagolix,NDA,2018,elagolix,DB11979,approved; investigational,COC1=CC=CC(=C1F)C1=C(C)N(CC2=C(C=CC=C2F)C(F)(F)F)C(=O)N(C[C@H](NCCCC(O)=O)C2=CC=CC=C2)C1=O,Elagolix,SmallMoleculeDrug,oral,631.2105621600001,7,2,5.535020000000005,102.56,12,9,0,1,1,0,1,0,1,1,1
417,lusutrombopag,NDA,2018,lusutrombopag,DB13125,approved; investigational,CCCCCCO[C@@H](C)C1=C(OC)C(=CC=C1)C1=CSC(NC(=O)C2=CC(Cl)=C(\C=C(/C)C(O)=O)C(Cl)=C2)=N1,Lusutrombopag,SmallMoleculeDrug,oral,590.1408984839999,6,2,8.523600000000005,97.75000000000001,13,8,0,1,1,0,1,0,1,1,1
418,migalastat,NDA,2018,migalastat,DB05018,approved; investigational,OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O,Migalastat,SmallMoleculeDrug,oral,163.084457896,5,5,-2.9667999999999988,92.95,1,10,1,1,1,1,1,1,1,1,3
419,stiripentol,NDA,2018,stiripentol,DB09118,approved,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1,Stiripentol,SmallMoleculeDrug,oral,234.125594436,3,1,2.835500000000001,38.69,2,4,1,1,1,1,1,1,1,1,3
420,eravacycline,NDA,2018,eravacycline,DB12329,approved; investigational,[H][C@@]12CC3=C(F)C=C(NC(=O)CN4CCCC4)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,Eravacycline,SmallMoleculeDrug,intravenous,558.2125921719999,10,6,0.2940000000000016,193.73000000000002,5,16,0,1,0,1,0,1,0,0,2
421,doravirine,NDA,2018,doravirine,DB12301,approved; investigational,CN1C(=O)NN=C1CN1C=CC(=C(OC2=CC(=CC(Cl)=C2)C#N)C1=O)C(F)(F)F,Doravirine,SmallMoleculeDrug,oral,425.050251552,7,1,2.654580000000001,105.69999999999999,4,8,1,1,1,1,1,1,1,1,3
422,duvelisib,NDA,2018,duvelisib,DB11952,approved; investigational,C[C@H](NC1=C2N=CNC2=NC=N1)C1=CC2=CC=CC(Cl)=C2C(=O)N1C1=CC=CC=C1,Duvelisib,SmallMoleculeDrug,oral,416.115236844,6,2,4.483500000000002,88.49000000000001,4,8,1,1,1,1,1,1,1,1,3
423,dacomitinib,NDA,2018,dacomitinib,DB11963,approved; investigational,COC1=C(NC(=O)\C=C\CN2CCCCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,Dacomitinib,SmallMoleculeDrug,oral,469.16808094,6,2,5.155100000000004,79.38000000000001,7,8,1,1,1,0,1,1,1,1,2
424,sarecycline,NDA,2018,sarecycline,DB12035,approved; investigational,[H][C@@]12CC3=C(CN(C)OC)C=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,Sarecycline,SmallMoleculeDrug,oral,487.195464888,10,5,0.1138000000000016,173.86,5,15,1,1,1,1,0,1,0,0,2
425,omadacycline,NDA,2018,omadacycline,DB12455,approved; investigational,[H][C@@]12CC3=C(C=C(CNCC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C,Omadacycline,SmallMoleculeDrug,oral intravenous,556.28969962,10,6,1.322300000000002,176.66000000000003,6,16,0,1,0,1,0,1,0,0,2
426,talazoparib,NDA,2018,talazoparib,DB11760,approved; investigational,CN1N=CN=C1[C@@H]1[C@H](NC2=C3C1=NNC(=O)C3=CC(F)=C2)C1=CC=C(F)C=C1,Talazoparib,SmallMoleculeDrug,oral,380.119715508,6,2,2.6285000000000007,88.49000000000001,2,8,1,1,1,1,1,1,1,1,3
427,baloxavir marboxil,NDA,2018,baloxavir marboxil,DB13997,approved; investigational,[H][C@@]12COCCN1C(=O)C1=C(OCOC(=O)OC)C(=O)C=CN1N2[C@H]1C2=CC=C(F)C(F)=C2CSC2=CC=CC=C12,Baloxavir marboxil,SmallMoleculeDrug,oral,571.122477516,10,0,3.391200000000002,99.54,4,10,0,1,1,1,1,1,1,1,3
428,lorlatinib,NDA,2018,lorlatinib,DB12130,approved; investigational,C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=C1C=C(F)C=C2,Lorlatinib,SmallMoleculeDrug,oral,406.155352068,7,1,2.8006800000000007,110.06,0,8,1,1,1,1,1,1,1,1,3
429,revefenacin,NDA,2018,revefenacin,DB11855,approved; investigational,CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1,Revefenacin,SmallMoleculeDrug,inhalation,597.3315048559999,6,2,4.836000000000004,108.21000000000001,10,8,0,1,1,1,1,1,1,1,3
430,rifamycin,NDA,2018,rifamycin,DB11753,approved; investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C=C(O)C4=C3C2=O,Rifamycin,SmallMoleculeDrug,oral,697.309825944,12,6,4.754120000000006,201.30999999999997,2,18,0,0,0,1,0,1,0,0,2
431,glasdegib,NDA,2018,glasdegib,DB11978,approved; investigational,CN1CC[C@H](C[C@@H]1C1=NC2=CC=CC=C2N1)NC(=O)NC1=CC=C(C=C1)C#N,Glasdegib,SmallMoleculeDrug,oral,374.185509324,4,3,3.391580000000001,96.84,3,7,1,1,1,1,1,1,1,1,3
432,larotrectinib,NDA,2018,larotrectinib,DB14723,approved; investigational,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=C(F)C=CC(F)=C1,Larotrectinib,SmallMoleculeDrug,oral,428.177230384,6,2,2.9475000000000016,86.0,3,8,1,1,1,1,1,1,1,1,3
433,amifampridine,NDA,2018,amifampridine,DB11640,approved; investigational,NC1=CC=NC=C1N,Amifampridine,SmallMoleculeDrug,oral,109.063997224,3,2,0.2460000000000001,64.92999999999999,0,5,1,1,1,1,1,1,1,1,3
434,gilteritinib,NDA,2018,gilteritinib,DB12141,approved; investigational,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O,Gilteritinib,SmallMoleculeDrug,oral,552.353637268,10,3,2.6972000000000005,121.11000000000001,9,13,0,1,1,1,1,1,0,1,3
435,prucalopride,NDA,2018,prucalopride,DB06480,approved,COCCCN1CCC(CC1)NC(=O)C1=C2OCCC2=C(N)C(Cl)=C1,Prucalopride,SmallMoleculeDrug,oral,367.166269372,5,2,2.0878000000000005,76.82,6,7,1,1,1,1,1,1,1,1,3
436,triclabendazole,NDA,2019,triclabendazole,DB12245,approved; investigational,CSC1=NC2=C(N1)C=C(Cl)C(OC1=CC=CC(Cl)=C1Cl)=C2,Triclabendazole,SmallMoleculeDrug,oral,357.950116948,3,1,6.037300000000002,37.91,3,4,1,1,1,0,1,1,1,1,2
437,brexanolone,NDA,2019,brexanolone,DB11859,approved; investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O,Brexanolone,SmallMoleculeDrug,intravenous,318.255880328,2,1,4.595200000000005,37.3,1,3,1,1,1,1,1,1,1,1,3
438,solriamfetol,NDA,2019,solriamfetol,DB14754,approved,N[C@@H](COC(N)=O)CC1=CC=CC=C1,Solriamfetol,SmallMoleculeDrug,oral,194.105527688,3,2,0.6516999999999996,78.34,4,5,1,1,1,1,1,1,1,1,3
439,siponimod,NDA,2019,siponimod,DB12371,approved; investigational,CCC1=CC(=CC=C1CN1CC(C1)C(O)=O)C(\C)=N\OCC1=CC=C(C2CCCCC2)C(=C1)C(F)(F)F,Siponimod,SmallMoleculeDrug,oral,516.25997764,4,1,6.772700000000008,62.129999999999995,9,5,0,1,1,0,1,1,1,1,2
440,erdafitinib,NDA,2019,erdafitinib,DB12147,approved; investigational,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1,Erdafitinib,SmallMoleculeDrug,oral,446.2430242000001,8,1,4.183600000000003,77.33,9,9,1,1,1,1,1,1,1,1,3
441,alpelisib,NDA,2019,alpelisib,DB12015,approved; investigational,CC1=C(SC(NC(=O)N2CCC[C@H]2C(N)=O)=N1)C1=CC(=NC=C1)C(C)(C)C(F)(F)F,Alpelisib,SmallMoleculeDrug,oral,441.144630604,5,2,3.835020000000002,101.21000000000001,4,7,1,1,1,1,1,1,1,1,3
442,bremelanotide,NDA,2019,bremelanotide,DB11653,approved; investigational,CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CN=CN2)NC1=O)C(O)=O,Bremelanotide,SmallMoleculeDrug,subcutaneous,1024.524284376,11,14,-0.4393300000000005,376.46999999999997,17,25,0,0,0,1,0,0,0,0,1
443,selinexor,NDA,2019,selinexor,DB11942,approved; investigational,FC(F)(F)C1=CC(=CC(=C1)C1=NN(\C=C/C(=O)NNC2=NC=CN=C2)C=N1)C(F)(F)F,Selinexor,SmallMoleculeDrug,oral,443.0929272920001,7,2,3.386700000000001,97.62,5,9,1,1,1,1,1,1,1,1,3
444,ferric maltol,NDA,2019,ferric maltol,DB15598,approved,[Fe+3].CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1,Ferric maltol,SmallMoleculeDrug,oral,434.0283739162699,9,3,1.95896,151.32,0,12,1,1,1,1,0,1,1,1,2
445,darolutamide,NDA,2019,darolutamide,DB12941,approved; investigational,C[C@@H](CN1C=CC(=N1)C1=CC=C(C#N)C(Cl)=C1)NC(=O)C1=NNC(=C1)C(C)O,Darolutamide,SmallMoleculeDrug,oral,398.125801528,6,3,2.670080000000001,119.62000000000002,6,9,1,1,1,1,1,1,1,1,3
446,pexidartinib,NDA,2019,pexidartinib,DB12978,approved; investigational,FC(F)(F)C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C34)C=C2)C=N1,Pexidartinib,SmallMoleculeDrug,oral,417.09680782,4,2,5.2280000000000015,66.49000000000001,5,6,1,1,1,0,1,1,1,1,2
447,pitolisant,NDA,2019,pitolisant,DB11642,approved; investigational,ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1,Pitolisant,SmallMoleculeDrug,oral,295.170292132,2,0,4.165200000000003,12.47,8,2,1,1,1,1,1,1,1,1,3
448,pretomanid,NDA,2019,pretomanid,DB05154,approved,[O-][N+](=O)C1=CN2C[C@@H](COC2=N1)OCC1=CC=C(OC(F)(F)F)C=C1,Pretomanid,SmallMoleculeDrug,oral,359.072905144,7,0,2.667700000000001,88.65,5,7,1,1,1,1,1,1,1,1,3
449,entrectinib,NDA,2019,entrectinib,DB11986,approved; investigational,CN1CCN(CC1)C1=CC=C(C(=O)NC2=NNC3=CC=C(CC4=CC(F)=CC(F)=C4)C=C23)C(NC2CCOCC2)=C1,Entrectinib,SmallMoleculeDrug,oral,560.271130768,6,3,5.026900000000003,85.52,7,9,0,1,1,0,1,1,1,1,2
450,fedratinib,NDA,2019,fedratinib,DB12500,approved; investigational,CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C,Fedratinib,SmallMoleculeDrug,oral,524.256960012,8,3,4.823620000000004,108.48000000000002,10,11,0,1,1,1,1,1,1,1,3
451,upadacitinib,NDA,2019,upadacitinib,DB15091,approved; investigational,CC[C@@H]1CN(C[C@@H]1C1=CN=C2C=NC3=C(C=CN3)N12)C(=O)NCC(F)(F)F,Upadacitinib,SmallMoleculeDrug,oral,380.157243888,4,2,2.9079000000000006,78.32,3,6,1,1,1,1,1,1,1,1,3
452,lefamulin,NDA,2019,lefamulin,DB12825,approved; investigational,[H][C@@]12C(=O)CC[C@]11CCC(C)[C@@]2(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]1C)OC(=O)CS[C@@H]1CC[C@@H](N)C[C@H]1O,Lefamulin,SmallMoleculeDrug,oral intravenous,507.30184453999993,7,3,3.8668000000000022,109.85000000000001,5,10,0,1,1,1,1,1,1,1,3
453,istradefylline,NDA,2019,istradefylline,DB11757,approved; investigational,[H]\C(=C(\[H])C1=CC(OC)=C(OC)C=C1)C1=NC2=C(N1C)C(=O)N(CC)C(=O)N2CC,Istradefylline,SmallMoleculeDrug,oral,384.179755248,8,0,2.1241000000000003,80.28,6,8,1,1,1,1,1,1,1,1,3
454,tenapanor,NDA,2019,tenapanor,DB11761,approved; investigational,CN1C[C@@H](C2=CC(=CC=C2)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C2=CC(=CC=C2)[C@@H]2CN(C)CC3=C2C=C(Cl)C=C3Cl)C2=C(C1)C(Cl)=CC(Cl)=C2,Tenapanor,SmallMoleculeDrug,oral,1142.3097430320004,12,6,6.15660000000001,217.99999999999997,29,18,0,0,0,0,0,0,0,0,0
455,trifarotene,NDA,2019,trifarotene,DB12808,approved; investigational,CC(C)(C)C1=CC(=CC=C1N1CCCC1)C1=CC(=CC=C1OCCO)C1=CC=C(C=C1)C(O)=O,Trifarotene,SmallMoleculeDrug,topical,459.240958536,4,2,5.987600000000007,70.0,7,6,1,1,1,0,1,1,1,1,2
456,afamelanotide,NDA,2019,afamelanotide,DB04931,approved; investigational,CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O,Afamelanotide,SmallMoleculeDrug,subcutaneous,1645.836510331999,21,23,-4.099729999999994,642.9799999999999,50,44,0,0,0,1,0,0,0,0,1
457,lasmiditan,NDA,2019,lasmiditan,DB11732,approved; investigational,CN1CCC(CC1)C(=O)C1=CC=CC(NC(=O)C2=C(F)C=C(F)C=C2F)=N1,Lasmiditan,SmallMoleculeDrug,oral,377.135111476,4,1,3.2757000000000014,62.300000000000004,4,5,1,1,1,1,1,1,1,1,3
458,zanubrutinib,NDA,2019,zanubrutinib,DB15035,approved; investigational,NC(=O)C1=C2NCC[C@@H](C3CCN(CC3)C(=O)C=C)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1,Zanubrutinib,SmallMoleculeDrug,oral,471.227039788,6,2,4.222600000000004,102.48000000000002,6,8,1,1,1,1,1,1,1,1,3
459,cefiderocol,NDA,2019,cefiderocol,DB14879,approved; investigational,[H][C@]12SCC(C[N+]3(CCNC(=O)C4=C(Cl)C(O)=C(O)C=C4)CCCC3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC(N)=N1)C([O-])=O,Cefiderocol,SmallMoleculeDrug,intravenous,752.1569864200901,13,7,1.1530000000000014,254.06999999999996,13,20,0,0,0,1,0,0,0,0,1
460,cenobamate,NDA,2019,cenobamate,DB06119,approved; investigational,NC(=O)O[C@@H](CN1N=CN=N1)C1=C(Cl)C=CC=C1,Cenobamate,SmallMoleculeDrug,oral,267.05230224,6,1,1.1630999999999998,95.92000000000002,4,7,1,1,1,1,1,1,1,1,3
461,voxelotor,NDA,2019,voxelotor,DB14975,approved; investigational,CC(C)N1N=CC=C1C1=C(COC2=CC=CC(O)=C2C=O)C=CC=N1,Voxelotor,SmallMoleculeDrug,oral,337.142641468,6,1,3.623100000000002,77.24,6,7,1,1,1,1,1,1,1,1,3
462,lumateperone,NDA,2019,lumateperone,DB06077,approved; investigational,[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=CC=CC3=C1N2CCN3C,Lumateperone,SmallMoleculeDrug,oral,393.221640736,4,0,3.9165000000000023,26.790000000000006,5,4,1,1,1,1,1,1,1,1,3
463,lemborexant,NDA,2019,lemborexant,DB11951,approved; investigational,CC1=NC=C(OC[C@]2(C[C@H]2C(=O)NC2=NC=C(F)C=C2)C2=CC=CC(F)=C2)C(C)=N1,Lemborexant,SmallMoleculeDrug,oral,410.15543232,5,1,3.742040000000002,77.0,6,6,1,1,1,1,1,1,1,1,3
464,ubrogepant,NDA,2019,ubrogepant,DB15328,approved; investigational,C[C@@H]1[C@@H](C[C@H](NC(=O)C2=CN=C3C[C@]4(CC3=C2)C(=O)NC2=NC=CC=C42)C(=O)N1CC(F)(F)F)C1=CC=CC=C1,Ubrogepant,SmallMoleculeDrug,oral,549.1987743520001,5,2,3.530600000000001,104.29,4,7,0,1,1,1,1,1,1,1,3
465,avapritinib,NDA,2020,avapritinib,DB15233,approved; investigational,CN1C=C(C=N1)C1=CN2N=CN=C(N3CCN(CC3)C3=NC=C(C=N3)[C@@](C)(N)C3=CC=C(F)C=C3)C2=C1,Avapritinib,SmallMoleculeDrug,oral,498.24041908400005,10,1,2.6077000000000004,106.29,5,11,1,1,1,1,1,1,1,1,3
466,tazemetostat,NDA,2020,tazemetostat,DB12887,approved; investigational,CCN(C1CCOCC1)C1=C(C)C(=CC(=C1)C1=CC=C(CN2CCOCC2)C=C1)C(=O)NCC1=C(C)C=C(C)NC1=O,Tazemetostat,SmallMoleculeDrug,oral,572.336255888,6,2,4.734660000000003,86.9,9,8,0,1,1,1,1,1,1,1,3
467,lactitol,NDA,2020,lactitol,DB12942,approved; investigational,OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO,Lactitol,SmallMoleculeDrug,oral,344.13186158799994,11,9,-5.761199999999992,200.52999999999997,8,20,1,0,0,1,0,1,0,0,2
468,bempedoic acid,NDA,2020,bempedoic acid,DB11936,approved; investigational,CC(C)(CCCCCC(O)CCCCCC(C)(C)C(O)=O)C(O)=O,Bempedoic acid,SmallMoleculeDrug,oral,344.2562742519999,3,3,4.469900000000003,94.83000000000001,14,6,1,1,1,1,1,0,1,1,2
469,amisulpride,NDA,2020,amisulpride,DB06288,approved; investigational,CCN1CCCC1CNC(=O)C1=CC(=C(N)C=C1OC)S(=O)(=O)CC,Amisulpride,SmallMoleculeDrug,intravenous,369.172227344,6,2,1.2851000000000006,101.72999999999999,7,8,1,1,1,1,1,1,1,1,3
470,rimegepant,NDA,2020,rimegepant,DB12457,approved; investigational,N[C@H]1[C@@H](CC[C@@H](OC(=O)N2CCC(CC2)N2C(=O)NC3=NC=CC=C23)C2=C1C=CC=N2)C1=C(F)C(F)=CC=C1,Rimegepant,SmallMoleculeDrug,oral,534.219095196,7,2,4.490000000000004,119.13,3,9,0,1,1,1,1,1,1,1,3
471,osilodrostat,NDA,2020,osilodrostat,DB11837,approved; investigational,FC1=C(C=CC(=C1)C#N)[C@H]1CCC2=CN=CN12,Osilodrostat,SmallMoleculeDrug,oral,227.08587554,3,0,2.42948,41.61,1,3,1,1,1,1,1,1,1,1,3
472,ozanimod,NDA,2020,ozanimod,DB12612,approved; investigational,CC(C)OC1=C(C=C(C=C1)C1=NC(=NO1)C1=C2CC[C@H](NCCO)C2=CC=C1)C#N,Ozanimod,SmallMoleculeDrug,oral,404.184840628,7,2,3.631680000000002,104.20000000000002,7,9,1,1,1,1,1,1,1,1,3
473,selumetinib,NDA,2020,selumetinib,DB11689,approved; investigational,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,SmallMoleculeDrug,oral,456.00000834,6,3,3.525600000000002,88.41000000000001,6,9,1,1,1,1,1,1,1,1,3
474,pemigatinib,NDA,2020,pemigatinib,DB15102,approved; investigational,CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F,Pemigatinib,SmallMoleculeDrug,oral,487.203110784,6,1,3.6570000000000022,83.16000000000001,6,7,1,1,1,1,1,1,1,1,3
475,tucatinib,NDA,2020,tucatinib,DB11652,approved; investigational,CC1=CC(NC2=NC=NC3=CC=C(NC4=NC(C)(C)CO4)C=C23)=CC=C1OC1=CC2=NC=NN2C=C1,Tucatinib,SmallMoleculeDrug,oral,480.202222008,10,2,5.093520000000004,110.85000000000001,5,12,1,1,1,0,1,1,1,1,2
476,opicapone,NDA,2020,opicapone,DB11632,approved; investigational,CC1=C(C2=NOC(=N2)C2=CC(=C(O)C(O)=C2)[N+]([O-])=O)C(Cl)=[N+]([O-])C(C)=C1Cl,Opicapone,SmallMoleculeDrug,oral,411.9977394,8,2,3.2800400000000023,149.46,3,10,1,1,1,1,0,1,1,1,2
477,capmatinib,NDA,2020,capmatinib,DB11791,approved; investigational,CNC(=O)C1=C(F)C=C(C=C1)C1=NN2C(CC3=CC4=C(C=C3)N=CC=C4)=CN=C2N=C1,Capmatinib,SmallMoleculeDrug,oral,412.1447873840001,6,1,3.429000000000001,85.07000000000001,4,7,1,1,1,1,1,1,1,1,3
478,selpercatinib,NDA,2020,selpercatinib,DB15685,approved; investigational,COC1=NC=C(CN2C3CC2CN(C3)C2=CC=C(C=N2)C2=CC(OCC(C)(C)O)=CN3N=CC(C#N)=C23)C=C1,Selpercatinib,SmallMoleculeDrug,oral,525.2488378520001,10,1,3.2843800000000014,112.03999999999999,8,11,0,1,1,1,1,1,1,1,3
479,ripretinib,NDA,2020,ripretinib,DB14840,approved,CCN1C(=O)C(=CC2=C1C=C(NC)N=C2)C1=C(Br)C=C(F)C(NC(=O)NC2=CC=CC=C2)=C1,Ripretinib,SmallMoleculeDrug,oral,509.086265232,5,3,5.670700000000004,88.05000000000001,5,8,0,1,1,0,1,1,1,1,2
480,artesunate,NDA,2020,artesunate,DB09274,approved; investigational,[H][C@@]12CC[C@@H](C)[C@]3([H])CC[C@@]4(C)OO[C@@]13[C@]([H])(O[C@@H](OC(=O)CCC(O)=O)[C@@H]2C)O4,Artesunate,SmallMoleculeDrug,intravenous,384.178417856,7,1,2.6024000000000003,100.52,4,8,1,1,1,1,1,1,1,1,3
481,lurbinectedin,NDA,2020,lurbinectedin,DB12674,approved; investigational,[H][C@@]12[C@@H]3SC[C@]4(NCCC5=C4NC4=CC=C(OC)C=C54)C(=O)OC[C@H](N1[C@@H](O)[C@@H]1CC4=CC(C)=C(OC)C(O)=C4[C@@]2([H])N1C)C1=C2OCOC2=C(C)C(OC(C)=O)=C31,Lurbinectedin,SmallMoleculeDrug,intravenous,784.277814608,14,4,4.188940000000003,164.27999999999997,3,18,0,0,1,1,0,1,0,0,2
482,triheptanoin,NDA,2020,triheptanoin,DB11677,approved; investigational,CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC,Triheptanoin,SmallMoleculeDrug,oral,428.313789128,6,0,5.895800000000007,78.9,20,6,1,1,1,0,1,0,1,1,1
483,remimazolam,NDA,2020,remimazolam,DB12404,approved; investigational,COC(=O)CC[C@@H]1N=C(C2=CC=CC=N2)C2=CC(Br)=CC=C2N2C(C)=CN=C12,Remimazolam,SmallMoleculeDrug,injection,438.0691379480001,6,0,4.183520000000003,69.37,4,6,1,1,1,1,1,1,1,1,3
484,fostemsavir,NDA,2020,fostemsavir,DB11796,approved; investigational,COC1=CN=C(N2C=NC(C)=N2)C2=C1C(=CN2COP(O)(O)=O)C(=O)C(=O)N1CCN(CC1)C(=O)C1=CC=CC=C1,Fostemsavir,SmallMoleculeDrug,oral,583.158047422,11,2,1.168119999999999,182.21,8,13,0,0,1,1,0,1,0,0,2
485,abametapir,NDA,2020,abametapir,DB11932,approved; investigational,CC1=CC=C(N=C1)C1=CC=C(C)C=N1,Abametapir,SmallMoleculeDrug,topical,184.100048384,2,0,2.760440000000001,25.78,1,2,1,1,1,1,1,1,1,1,3
486,nifurtimox,NDA,2020,nifurtimox,DB11820,approved; investigational,CC1CS(=O)(=O)CCN1\N=C\C1=CC=C(O1)[N+]([O-])=O,Nifurtimox,SmallMoleculeDrug,oral,287.057591516,7,0,0.6405999999999996,106.02000000000001,3,7,1,1,1,1,1,1,1,1,3
487,risdiplam,NDA,2020,risdiplam,DB15305,approved; investigational,CC1=CN2N=C(C=C(C)C2=N1)C1=CC(=O)N2C=C(C=CC2=N1)N1CCNC2(CC2)C1,Risdiplam,SmallMoleculeDrug,oral,401.1964083560001,8,1,1.96324,79.83,2,9,1,1,1,1,1,1,1,1,3
488,oliceridine,NDA,2020,oliceridine,DB14881,approved; investigational,COC1=C(CNCC[C@]2(CCOC3(CCCC3)C2)C2=NC=CC=C2)SC=C1,Oliceridine,SmallMoleculeDrug,intravenous,386.2027992,5,1,4.692600000000005,43.379999999999995,7,6,1,1,1,1,1,1,1,1,3
489,clascoterone,NDA,2020,clascoterone,DB12499,approved; investigational,[H][C@@]12CC[C@](OC(=O)CC)(C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,Clascoterone,SmallMoleculeDrug,topical,402.240624188,5,1,3.7717000000000023,80.67000000000002,4,6,1,1,1,1,1,1,1,1,3
490,pralsetinib,NDA,2020,pralsetinib,DB15822,approved; investigational,CO[C@]1(CC[C@@H](CC1)C1=NC(NC2=NNC(C)=C2)=CC(C)=N1)C(=O)N[C@@H](C)C1=CC=C(N=C1)N1C=C(F)C=N1,Pralsetinib,SmallMoleculeDrug,oral,533.2662994840001,9,3,4.200140000000003,135.52999999999997,8,12,0,1,1,1,1,1,1,1,3
491,remdesivir,NDA,2020,remdesivir,DB14761,approved; investigational,CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)C1=CC=C2N1N=CN=C2N)OC1=CC=CC=C1,Remdesivir,SmallMoleculeDrug,intravenous,602.2253987099999,13,4,2.312179999999999,203.55,13,17,0,0,1,1,0,0,0,0,1
492,lonafarnib,NDA,2020,lonafarnib,DB06448,approved; investigational,NC(=O)N1CCC(CC(=O)N2CCC(CC2)[C@H]2C3=C(CCC4=C2C(Br)=CC(Cl)=C4)C=C(Br)C=N3)CC1,Lonafarnib,SmallMoleculeDrug,oral,636.0502281119999,3,1,5.909900000000006,79.53,3,4,0,1,1,0,1,1,1,1,2
493,setmelanotide,NDA,2020,setmelanotide,DB11700,approved; investigational,[H]N([H])C(=O)[C@@H]1CSSC[C@H](N([H])C(=O)[C@H](CCCN=C(N([H])[H])N([H])[H])N([H])C(C)=O)C(=O)N[C@H](C)C(=O)N[C@@H](CC2=CN=CN2[H])C(=O)N[C@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC2=CN([H])C3=CC=CC=C23)C(=O)N1,Setmelanotide,SmallMoleculeDrug,subcutaneous,1116.485807756,14,15,-3.1754000000000167,449.15999999999985,18,29,0,0,0,1,0,0,0,0,1
494,berotralstat,NDA,2020,berotralstat,DB15982,approved,NCC1=CC(=CC=C1)N1N=C(C=C1C(=O)NC1=CC(=CC=C1F)[C@H](NCC1CC1)C1=CC=CC(=C1)C#N)C(F)(F)F,Berotralstat,SmallMoleculeDrug,oral,562.2104223320001,6,3,5.7018800000000045,108.75999999999999,9,9,0,1,1,0,1,1,1,1,2
495,tirbanibulin,NDA,2020,tirbanibulin,DB06137,approved; investigational,O=C(CC1=CC=C(C=N1)C1=CC=C(OCCN2CCOCC2)C=C1)NCC1=CC=CC=C1,Tirbanibulin,SmallMoleculeDrug,topical,431.2208917880001,5,1,3.318500000000002,63.69,9,6,1,1,1,1,1,1,1,1,3
496,relugolix,NDA,2020,relugolix,DB11853,approved; investigational,CONC(=O)NC1=CC=C(C=C1)C1=C(CN(C)C)C2=C(S1)N(CC1=C(F)C=CC=C1F)C(=O)N(C2=O)C1=CC=C(OC)N=N1,Relugolix,SmallMoleculeDrug,oral,623.1762444039999,11,2,3.7505000000000015,132.61,9,13,0,0,1,1,1,1,0,1,3
497,vibegron,NDA,2020,vibegron,DB14895,approved; investigational,[H][C@@]1(CC[C@@H](CC2=CC=C(NC(=O)[C@@H]3CCC4=NC=CC(=O)N34)C=C2)N1)[C@H](O)C1=CC=CC=C1,Vibegron,SmallMoleculeDrug,oral,444.216140756,6,3,2.766,96.25,6,9,1,1,1,1,1,1,1,1,3
498,vericiguat,NDA,2021,vericiguat,DB15456,approved; investigational,COC(=O)NC1=C(N)N=C(N=C1N)C1=NN(CC2=CC=CC=C2F)C2=C1C=C(F)C=N2,Vericiguat,SmallMoleculeDrug,oral,426.136428192,9,3,2.5575,146.86,4,12,1,1,1,1,0,1,1,1,2
499,voclosporin,NDA,2021,voclosporin,DB11693,approved; investigational,[H][C@@]1([C@H](O)[C@H](C)C\C=C\C=C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC1=O)C(C)C,Voclosporin,SmallMoleculeDrug,oral,1213.8413679919995,12,5,3.435100000000003,278.79999999999995,16,17,0,0,1,1,0,0,0,0,1
500,tepotinib,NDA,2021,tepotinib,DB15133,approved; investigational,CN1CCC(COC2=CN=C(N=C2)C2=CC(CN3N=C(C=CC3=O)C3=CC(=CC=C3)C#N)=CC=C2)CC1,Tepotinib,SmallMoleculeDrug,oral,492.227374136,8,0,4.007880000000004,96.93,7,8,1,1,1,1,1,1,1,1,3
501,umbralisib,NDA,2021,umbralisib,DB14989,approved; investigational,CC(C)OC1=C(F)C=C(C=C1)C1=NN([C@@H](C)C2=C(C3=CC=CC(F)=C3)C(=O)C3=CC(F)=CC=C3O2)C2=C1C(N)=NC=N2,Umbralisib,SmallMoleculeDrug,oral,571.1831242879999,8,1,6.6627000000000045,109.06,6,9,0,1,1,0,1,1,1,1,2
502,trilaciclib,NDA,2021,trilaciclib,DB15442,approved; investigational,CN1CCN(CC1)C1=CN=C(NC2=NC3=C(C=C4N3C3(CCCCC3)CNC4=O)C=N2)C=C1,Trilaciclib,SmallMoleculeDrug,intravenous,446.25425758,8,2,2.7245,91.21,3,10,1,1,1,1,1,1,1,1,3
503,fosdenopterin,NDA,2021,fosdenopterin,DB16628,approved,[H][C@@]12COP(O)(=O)O[C@]1([H])C(O)(O)[C@]1([H])NC3=C(NC(N)=NC3=O)N[C@]1([H])O2,Fosdenopterin,SmallMoleculeDrug,intravenous,363.0579990380001,11,7,-2.5203,201.28000000000003,0,18,1,0,0,1,0,1,0,0,2
504,melphalan flufenamide,NDA,2021,melphalan flufenamide,DB16627,approved; withdrawn,CCOC(=O)[C@H](CC1=CC=C(F)C=C1)NC(=O)[C@@H](N)CC1=CC=C(C=C1)N(CCCl)CCCl,Melphalan flufenamide,SmallMoleculeDrug,injection,497.1648254,5,2,3.270100000000002,84.66,13,7,1,1,1,1,1,0,1,1,2
505,tivozanib,NDA,2021,tivozanib,DB11800,approved; investigational,COC1=C(OC)C=C2C(OC3=CC(Cl)=C(NC(=O)NC4=NOC(C)=C4)C=C3)=CC=NC2=C1,Tivozanib,SmallMoleculeDrug,oral,454.10439738800005,7,2,5.638120000000003,107.74,6,9,1,1,1,0,1,1,1,1,2
506,ponesimod,NDA,2021,ponesimod,DB12016,approved; investigational,CCC\N=C1/S\C(=C/C2=CC=C(OC[C@H](O)CO)C(Cl)=C2)C(=O)N1C1=CC=CC=C1C,Ponesimod,SmallMoleculeDrug,oral,460.12235596,6,2,4.267320000000003,82.36,8,8,1,1,1,1,1,1,1,1,3
507,viloxazine,NDA,2021,viloxazine,DB09185,approved; investigational; withdrawn,CCOC1=CC=CC=C1OCC1CNCCO1,Viloxazine,SmallMoleculeDrug,oral,237.136493468,4,1,1.4525,39.72,5,5,1,1,1,1,1,1,1,1,3
508,sotorasib,NDA,2021,sotorasib,DB15569,approved; investigational,CC(C)C1=NC=CC(C)=C1N1C(=O)N=C(N2CCN(C[C@@H]2C)C(=O)C=C)C2=CC(F)=C(N=C12)C1=C(O)C=CC=C1F,Sotorasib,SmallMoleculeDrug,oral,560.2347452600001,8,1,4.481420000000005,104.45000000000002,5,9,0,1,1,1,1,1,1,1,3
509,infigratinib,NDA,2021,infigratinib,DB11886,approved; investigational,CCN1CCN(CC1)C1=CC=C(NC2=CC(=NC=N2)N(C)C(=O)NC2=C(Cl)C(OC)=CC(OC)=C2Cl)C=C1,Infigratinib,SmallMoleculeDrug,oral,559.1865432119998,8,2,5.3544000000000045,95.09,8,10,0,1,1,0,1,1,1,1,2
510,ibrexafungerp,NDA,2021,ibrexafungerp,DB12471,approved; investigational,[H][C@]12CC[C@@]3([H])[C@@]4(C)COC[C@@]3(C[C@H]([C@@H]4OC[C@](C)(N)C(C)(C)C)N3N=CN=C3C3=CC=NC=C3)C1=CC[C@@]1(C)[C@H](C(O)=O)[C@](C)(CC[C@]21C)[C@H](C)C(C)C,Ibrexafungerp,SmallMoleculeDrug,oral,729.5193056240003,8,2,8.618400000000005,125.38,8,10,0,1,1,0,1,1,1,1,2
511,finerenone,NDA,2021,finerenone,DB16165,approved; investigational,CCOC1=NC=C(C)C2=C1[C@H](C1=CC=C(C=C1OC)C#N)C(C(N)=O)=C(C)N2,Finerenone,SmallMoleculeDrug,oral,378.169190564,6,2,2.9857000000000005,110.25999999999999,5,8,1,1,1,1,1,1,1,1,3
512,fexinidazole,NDA,2021,fexinidazole,DB12265,approved; investigational,CSC1=CC=C(OCC2=NC=C(N2C)[N+]([O-])=O)C=C1,Fexinidazole,SmallMoleculeDrug,oral,279.06776227600005,6,0,2.629200000000001,70.19,5,6,1,1,1,1,1,1,1,1,3
513,belumosudil,NDA,2021,belumosudil,DB16703,approved; investigational,CC(C)NC(=O)COC1=CC=CC(=C1)C1=NC2=C(C=CC=C2)C(NC2=CC=C3NN=CC3=C2)=N1,Belumosudil,SmallMoleculeDrug,oral,452.1960740080001,6,3,4.820100000000003,104.82,7,9,1,1,1,1,1,1,1,1,3
514,odevixibat,NDA,2021,odevixibat,DB16261,approved; investigational,CCCCC1(CCCC)CN(C2=CC=CC=C2)C2=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C3=CC=C(O)C=C3)C=C2S(=O)(=O)N1,Odevixibat,SmallMoleculeDrug,oral,740.2913564959999,9,5,5.879000000000006,174.36999999999998,17,14,0,1,1,0,0,0,0,0,0
515,belzutifan,NDA,2021,belzutifan,DB15463,approved; investigational,CS(=O)(=O)C1=CC=C(OC2=CC(=CC(F)=C2)C#N)C2=C1[C@H](O)[C@H](F)[C@@H]2F,Belzutifan,SmallMoleculeDrug,oral,383.043913524,5,1,3.2888800000000016,87.39,3,6,1,1,1,1,1,1,1,1,3
516,difelikefalin,NDA,2021,difelikefalin,DB11938,approved; investigational,CC(C)C[C@@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O,Difelikefalin,SmallMoleculeDrug,intravenous,679.4057324160001,8,7,0.8331000000000075,222.97,18,15,0,1,0,1,0,0,0,0,1
517,mobocertinib,NDA,2021,mobocertinib,DB16390,approved; investigational,COC1=C(NC2=NC=C(C(=O)OC(C)C)C(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C,Mobocertinib,SmallMoleculeDrug,oral,585.306352728,10,2,5.075000000000004,113.85,12,12,0,1,1,0,1,0,1,1,1
518,atogepant,NDA,2021,atogepant,DB16098,approved; investigational,C[C@@H]1[C@@H](C[C@H](NC(=O)C2=CN=C3C[C@]4(CC3=C2)C(=O)NC2=C4C=CC=N2)C(=O)N1CC(F)(F)F)C1=C(F)C(F)=CC=C1F,Atogepant,SmallMoleculeDrug,oral,603.170508916,5,2,3.9479000000000033,104.29,4,7,0,1,1,1,1,1,1,1,3
519,maralixibat,NDA,2021,maralixibat,DB16226,approved; investigational,CCCCC1(CCCC)CS(=O)(=O)C2=CC=C(C=C2[C@H]([C@H]1O)C1=CC=C(OCC2=CC=C(C[N+]34CCN(CC3)CC4)C=C2)C=C1)N(C)C,Maralixibat,SmallMoleculeDrug,oral,674.39860469209,6,1,6.624500000000007,70.08,13,7,0,1,1,0,1,0,1,1,1
520,avacopan,NDA,2021,avacopan,DB15011,approved; investigational,CC1=CC=C(NC(=O)[C@H]2CCCN([C@H]2C2=CC=C(NC3CCCC3)C=C2)C(=O)C2=C(F)C=CC=C2C)C=C1C(F)(F)F,Avacopan,SmallMoleculeDrug,oral,581.2665402399999,3,2,8.048040000000006,61.440000000000005,6,5,0,1,1,0,1,1,1,1,2
521,asciminib,NDA,2021,asciminib,DB12597,approved; investigational,O[C@@H]1CCN(C1)C1=C(C=C(C=N1)C(=O)NC1=CC=C(OC(F)(F)Cl)C=C1)C1=CC=NN1,Asciminib,SmallMoleculeDrug,oral,449.1066235560001,6,3,3.462900000000001,103.37,6,9,1,1,1,1,1,1,1,1,3
522,maribavir,NDA,2021,maribavir,DB06234,approved; investigational,CC(C)NC1=NC2=CC(Cl)=C(Cl)C=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O,Maribavir,SmallMoleculeDrug,oral,375.075261448,7,4,1.7748999999999993,99.77000000000001,4,11,1,1,1,1,1,1,1,1,3
523,pafolacianine,NDA,2021,pafolacianine,DB15413,approved; investigational,CC1(C)\C(=C/C=C2\CCCC(\C=C\C3=[N+](CCCCS(O)(=O)=O)C4=C(C=C(C=C4)S([O-])(=O)=O)C3(C)C)=C2OC2=CC=C(C[C@H](NC(=O)C3=CC=C(NCC4=CN=C5N=C(N)NC(=O)C5=N4)C=C3)C(O)=O)C=C2)N(CCCCS(O)(=O)=O)C2=C1C=C(C=C2)S(O)(=O)=O,Pafolacianine,SmallMoleculeDrug,intravenous,1326.3610521360893,18,9,7.220000000000007,408.94,25,27,0,0,0,0,0,0,0,0,0
524,tiludronate disodium,NDA,1997,tiludronate,DB01133,approved; investigational,OP(O)(=O)C(SC1=CC=C(Cl)C=C1)P(O)(O)=O,Tiludronic acid,SmallMoleculeDrug,oral,317.928359948,3,4,2.0711000000000013,115.06,4,7,1,1,1,1,1,1,1,1,3
525,risedronate sodium,NDA,1998,risedronate,DB00884,approved; investigational,OC(Cc1cccnc1)([P](O)(O)=O)[P](O)(O)=O,Risedronic acid,SmallMoleculeDrug,oral,283.001074952,4,5,-0.3744,148.18,4,9,1,1,1,1,0,1,1,1,2
526,eptifibatide,NDA,1998,eptifibatide,DB00063,approved; investigational,NC(N)=NCCCCC1NC(=O)CCSSCC(NC(=O)C2CCCN2C(=O)C(Cc3c[nH]c4ccccc34)NC(=O)C(CC(O)=O)NC(=O)CNC1=O)C(N)=O,,,,831.3156141480001,11,10,-2.054399999999992,326.38999999999993,10,21,0,0,0,1,0,1,0,0,2
527,pemirolast potassium,NDA,1999,pemirolast potassium,DB00885,approved; investigational,CC1=CC=CN2C(=O)C(=CN=C12)C1=NNN=N1,Pemirolast,SmallMoleculeDrug,ophtalmic,228.075958876,6,1,0.1830199999999998,88.83,1,7,1,1,1,1,1,1,1,1,3
528,triptorelin pamoate,NDA,2000,triptorelin pamoate,DB06825,approved; vet approved,CC(C)C[C@H](NC(=O)[C@@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,Triptorelin,SmallMoleculeDrug,intramuscular,1310.6308746839995,15,18,-2.085130000000012,487.9199999999998,33,33,0,0,0,1,0,0,0,0,1
529,unoprostone isopropyl,NDA,2000,unoprostone isopropyl,DBSALT001760,approved,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\CCCC(=O)OC(C)C)O)O,,,intravenous,424.3188745079999,5,2,5.122300000000007,83.83000000000001,16,7,1,1,1,0,1,0,1,1,1
530,perflutren lipid microsphere,NDA,2001,perflutren,DB00556,approved,FC(F)(F)C(F)(F)C(F)(F)F,Perflutren,SmallMoleculeDrug,intravenous,187.98722576,0,0,2.7463,0.0,0,0,1,1,1,1,1,1,1,1,3
531,cefditoren pivoxil,NDA,2001,cefditoren pivoxil,DBSALT001811,approved,[H][C@]12SCC(\C=C/C3=C(C)N=CS3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(=O)OCOC(=O)C(C)(C)C,,,,620.118160236,14,2,2.29812,175.39999999999998,9,16,0,0,1,1,0,1,0,0,2
532,olmesartan medoxomil,NDA,2002,olmesartan medoxomil,DB00275,approved; investigational,CCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4n[nH]nn4)C(=O)OCC5=C(C)OC(=O)O5)C(C)(C)O,Olmesartan,SmallMoleculeDrug,oral,558.22268268,11,2,4.170020000000004,162.16,10,13,0,0,1,1,0,1,0,0,2
533,sodium oxybate,NDA,2002,oxybate,DB09072,approved,C(CC(=O)O)CO,Sodium oxybate,SmallMoleculeDrug,ophthalmic,104.047344116,2,2,-0.1564999999999999,57.53,3,4,1,1,1,1,1,1,1,1,3
534,icodextrin,NDA,2002,icodextrin,DB00702,approved; investigational,OC[C@H]1OC(O[C@H]2[C@H](O)[C@@H](O)C(O[C@@H]2CO)O[C@H]3[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]3CO)[C@H](O)[C@@H](O)[C@@H]1O,Icodextrin,SmallMoleculeDrug,intraperitoneal,504.1690349439998,16,11,-7.572999999999989,268.67999999999995,7,27,0,0,0,1,0,1,0,0,2
535,pentetate calcium trisodium,NDA,2004,pentetate,DB06806,approved,[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O,,,oral,393.138343936,8,5,-2.684599999999993,196.22,16,13,1,1,1,1,0,0,0,0,1
536,pentetate zinc trisodium,NDA,2004,pentetate zinc,DB14007,approved,OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CCN(CC(O)=O)CC(O)=O,Pentetic acid,SmallMoleculeDrug,injection inhalation,393.138343936,8,5,-2.684599999999993,196.22,16,13,1,1,1,1,0,0,0,0,1
537,lanthanum carbonate hydrate,NDA,2004,lanthanum carbonate hydrate,DB06792,approved,O.[La+3].[La+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O,Lanthanum carbonate,SmallMoleculeDrug,oral,481.8211615765398,3,6,-0.1574999999999996,204.08999999999997,0,9,1,1,0,1,0,1,1,1,2
538,gadobenate dimeglumine,NDA,2004,gadobenate dimeglumine,DB00743,approved; investigational,[Gd+3].OC(=O)CN(CCN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)C(COCC1=CC=CC=C1)C(O)=O,Gadobenic acid,SmallMoleculeDrug,intravenous,513.1958588119999,9,5,-1.099199999999991,205.44999999999996,20,14,0,1,1,1,0,0,0,0,1
539,trypan blue,NDA,2004,trypan blue,DB09158,approved,CC1=CC(=CC=C1\N=N\C1=C(C=C2C=C(C=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C=C(C=C2C=C1S(O)(=O)=O)S(O)(=O)=O,Trypan blue free acid,SmallMoleculeDrug,intravenous,872.054633576,16,8,6.670040000000006,359.42,9,24,0,0,0,0,0,1,0,0,1
540,clofarbine,NDA,2004,clofarbine,DB00631,approved,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,Clofarabine,SmallMoleculeDrug,injection,303.0534451120001,8,3,-0.3494000000000003,119.30999999999999,2,11,1,1,1,1,1,1,1,1,3
541,fosaprepitant dimeglumine,NDA,2008,fosaprepitant dimeglumine,DB06717,approved,C[C@@H](O[C@H]1OCCN(CC2=NC(=O)N(N2)P(O)(O)=O)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,Fosaprepitant,SmallMoleculeDrug,intravenous,614.116518594,7,3,4.366300000000004,129.91,7,10,0,1,1,1,1,1,1,1,3
542,gadoxetate disodium,NDA,2008,gadoxetate,DB08884,approved,[Gd+3].[H][C@@](CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)(CC1=CC=C(OCC)C=C1)N(CC(O)=O)CC(O)=O,Gadoxetic acid,SmallMoleculeDrug,intravenous,527.2115088759999,9,5,-0.6745999999999923,205.45,20,14,0,1,1,1,0,0,0,0,1
543,omacetaxine mepesuccinate,NDA,2012,omacetaxine,DB04865,approved,[H][C@@]1(OC(=O)[C@@](O)(CCCC(C)(C)O)CC(=O)OC)C(OC)=C[C@]23CCCN2CCC2=CC4=C(OCO4)C=C2[C@]13[H],Omacetaxine mepesuccinate,SmallMoleculeDrug,subcutaneous,545.262481828,10,2,2.5807,123.99000000000002,9,12,0,1,1,1,1,1,1,1,3
544,gadoterate meglumine,NDA,2013,gadoterate meglumine,DB09132,approved,[Gd+3].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)CN1CCN(CCN(CCN(CC1)CC([O-])=O)CC([O-])=O)CC([O-])=O,Gadoteric acid,SmallMoleculeDrug,intravenous,599.3013865000001,14,10,-5.811900000000009,275.34,14,24,0,0,0,1,0,0,0,0,1
545,dimethyl fumarate,NDA,2013,dimethyl fumarate,DB08908,approved; investigational,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,Dimethyl fumarate,SmallMoleculeDrug,oral,144.042258736,4,0,-0.1114000000000001,52.60000000000001,2,4,1,1,1,1,1,1,1,1,3
546,dalbavancin,NDA,2014,dalbavancin,DB06219,approved; investigational,CN[C@H]1C(=O)N[C@@H]2Cc3ccc(Oc4cc5cc(Oc6ccc(cc6Cl)[C@@H](O)[C@@H]7NC(=O)[C@H](NC(=O)[C@@H]5NC(=O)[C@@H](NC2=O)c8cc(Oc9cc1ccc9O)cc(O)c8Cl)c%10ccc(O)c(c%10)c%11c(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]%12O)cc(O)cc%11[C@@H](NC7=O)C(=O)NCCCN(C)C)c4O[C@@H]%13O[C@@H]([C@@H](O)[C@H](O)[C@H]%13NC(=O)CCCCCCCCC(C)C)C(O)=O)cc3,Dalbavancin,SmallMoleculeDrug,intravenous,1814.6085579199992,29,21,4.168000000000005,572.5100000000002,22,50,0,0,0,1,0,0,0,0,1
547,tafamidis meglumine,NDA,2019,tafamidis meglumine,DB11644,approved; investigational,OC(=O)C1=CC=C2N=C(OC2=C1)C1=CC(Cl)=CC(Cl)=C1,Tafamidis,SmallMoleculeDrug,oral,306.980298444,3,1,4.499800000000001,63.33,2,4,1,1,1,1,1,1,1,1,3
548,Brilliant Blue G Ophthalmic Solution,NDA,2019,Brilliant Blue G Ophthalmic Solution,DB15594,approved,[Na+].CCOC1=CC=C(NC2=CC=C(C=C2)C(=C2\C=C/C(/C=C2C)=[N+](/CC)CC2=CC(=CC=C2)S([O-])(=O)=O)\C2=C(C)C=C(C=C2)N(CC)CC2=CC(=CC=C2)S([O-])(=O)=O)C=C1,Brilliant blue G,SmallMoleculeDrug,ophthalmic,832.3084693600902,7,3,9.648820000000002,136.25,15,10,0,1,1,0,1,0,1,1,1
549,daridorexant,NDA,2022,daridorexant,DB15031,approved,COC1=CC(C(=O)N2CCC[C@@]2(C)C2=NC3=C(N2)C=CC(Cl)=C3C)=C(C=C1)N1N=CC=N1,Daridorexant,SmallMoleculeDrug,oral,450.15710165600007,6,1,4.265420000000002,88.92999999999999,4,7,1,1,1,1,1,1,1,1,3
550,abrocitinib,NDA,2022,abrocitinib,DB14973,approved,CCCS(=O)(=O)N[C@H]1C[C@H](C1)N(C)C1=C2C=CNC2=NC=N1,Abrocitinib,SmallMoleculeDrug,oral,323.14159591200007,5,2,1.2544999999999995,90.98,6,7,1,1,1,1,1,1,1,1,3
551,mitapivat,NDA,2022,mitapivat,DB16236,approved,O=C(N1CCN(CC2CC2)CC1)C1=CC=C(NS(=O)(=O)C2=CC=CC3=C2N=CC=C3)C=C1,Mitapivat,SmallMoleculeDrug,oral,450.172561692,5,1,3.203400000000001,82.61,6,6,1,1,1,1,1,1,1,1,3
552,pacritinib,NDA,2022,pacritinib,DB11697,approved,C(CN1CCCC1)OC1=CC=C2NC3=NC=CC(=N3)C3=CC(COC\C=C\COCC1=C2)=CC=C3,Pacritinib,SmallMoleculeDrug,oral,472.247440884,7,1,4.964800000000005,68.74000000000001,4,8,1,1,1,1,1,1,1,1,3
553,ganaxolone,NDA,2022,ganaxolone,DB05087,approved,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@](C)(O)CC[C@]12C,Ganaxolone,SmallMoleculeDrug,oral,332.271530392,2,1,4.985300000000006,37.3,1,3,1,1,1,1,1,1,1,1,3
554,oteseconazole,NDA,2022,oteseconazole,DB13055,approved,O[C@@](CN1C=NN=N1)(C1=CC=C(F)C=C1F)C(F)(F)C1=CC=C(C=N1)C1=CC=C(OCC(F)(F)F)C=C1,Oteseconazole,SmallMoleculeDrug,oral,527.119222292,7,1,4.634200000000002,85.95,8,8,0,1,1,1,1,1,1,1,3
555,mavacamten,NDA,2022,mavacamten,DB14921,approved,CC(C)N1C(=O)NC(N[C@@H](C)C2=CC=CC=C2)=CC1=O,Mavacamten,SmallMoleculeDrug,oral,273.147726848,4,2,2.2906000000000004,66.89,4,6,1,1,1,1,1,1,1,1,3
556,tapinarof,NDA,2022,tapinarof,DB06083,approved,CC(C)C1=C(O)C=C(\C=C\C2=CC=CC=C2)C=C1O,Tapinarof,SmallMoleculeDrug,topical,254.130679816,2,2,4.391600000000004,40.46,3,4,1,1,1,1,1,1,1,1,3
557,deucravacitinib,NDA,2022,deucravacitinib,DB16650,approved,[2H]C([2H])([2H])NC(=O)C1=C(NC2=CC=CC(C3=NN(C)C=N3)=C2OC)C=C(NC(=O)C2CC2)N=N1,Deucravacitinib,SmallMoleculeDrug,oral,425.2003168020001,9,3,1.7323999999999993,135.95000000000002,8,12,1,1,1,1,1,1,1,1,3
558,omidenepag,NDA,2022,omidenepag,DB15071,approved,CC(C)OC(=O)CNC1=CC=CC(CN(CC2=CC=C(C=C2)N2C=CC=N2)S(=O)(=O)C2=CC=CN=C2)=N1,Omidenepag,SmallMoleculeDrug,ophthalmic,520.1892743760001,9,1,3.416900000000002,119.31,11,10,0,1,1,1,1,0,1,1,2
559,futibatinib,NDA,2022,futibatinib,DB15149,approved,COC1=CC(=CC(OC)=C1)C#CC1=NN([C@H]2CCN(C2)C(=O)C=C)C2=C1C(N)=NC=N2,Futibatinib,SmallMoleculeDrug,oral,418.175338564,8,1,1.7848999999999997,108.39,4,9,1,1,1,1,1,1,1,1,3
560,olutasidenib,NDA,2022,olutasidenib,DB16267,approved,C[C@H](NC1=CC=C(C#N)N(C)C1=O)C1=CC2=C(NC1=O)C=CC(Cl)=C2,Olutasidenib,SmallMoleculeDrug,oral,354.0883534,5,2,2.9249800000000006,90.68,3,7,1,1,1,1,1,1,1,1,3
561,adagrasib,NDA,2022,adagrasib,DB15568,approved,[H][C@@]1(COC2=NC3=C(CCN(C3)C3=CC=CC4=C3C(Cl)=CC=C4)C(=N2)N2CCN(C(=O)C(F)=C)[C@@]([H])(CC#N)C2)CCCN1C,Adagrasib,SmallMoleculeDrug,oral,603.2524792600001,8,0,4.732980000000004,88.83,7,8,0,1,1,1,1,1,1,1,3
562,lenacapavir,NDA,2022,lenacapavir,DB15673,approved,[H][C@]12C[C@@]1([H])C(F)(F)C1=C2C(=NN1CC(=O)N[C@@H](CC1=CC(F)=CC(F)=C1)C1=NC(=CC=C1C1=CC=C(Cl)C2=C1N(CC(F)(F)F)N=C2NS(C)(=O)=O)C#CC(C)(C)S(C)(=O)=O)C(F)(F)F,Lenacapavir,SmallMoleculeDrug,subcutaneous,967.1435190040002,10,2,7.662800000000008,157.94,11,12,0,1,1,0,0,0,1,1,0
